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A qualitative study of urban people of color living with human immunodeficiency virus: 





Background: Despite advances in HIV medication, many people living with HIV (PLWH) do not 
link to care upon diagnosis, do not remain engaged if linked, and do not achieve viral 
suppression through consistent ART adherence. Not achieving viral suppression is associated 
with low CD4-cell counts, preventable hospitalizations, frequent emergency room usage, risk of 
developing a drug resistance, and excess morbidity and mortality. Despite extensive literature 
that explores barriers to care, these disparities remain, particularly among racial, ethnic and 
sexual minority groups. Mistrust of health care systems and/or providers is thought to provide a 
partial explanation for why racial and ethnic minority groups are less likely to access outpatient 
HIV care. One form of health-related mistrust, referred to as “conspiracy beliefs” in the literature 
and in popular culture, is particularly associated with racial and ethnic minority people. HIV-
related “conspiracy beliefs” can include the ideas that the government created HIV to target 
specific minority groups, that antiretroviral medication is used to experiment on vulnerable 
groups, or that a cure is being withheld or delayed by pharmaceutical companies and/or the 
government. Although many studies have assessed the prevalence of such beliefs, little is known 
about the possible relationship between endorsing these ideas and engagement from HIV 
	
	
care/ART adherence among PLWH. Moreover, the extant literature has provided equivocal 
findings that point to the need for further research on the relationship between these beliefs and 
managing one’s HIV. 
Methods: Over the course of one year, 27 semi-structured, in-depth interviews were conducted 
with low income PLWH of color living in the NYC area that are currently, or were recently, 
disengaged from outpatient HIV medical care. Additionally, a brief questionnaire was 
administered to obtain demographic and engagement/medication adherence data to describe the 
sample of participants. 
Findings: This analysis revealed the variation, texture and diversity related to people’s beliefs 
about the origin and treatment of HIV. Beliefs about the pharmaceutical industry and the 
government highlighted both the racism and classism experienced by low income who belong to 
racial and ethnic minority groups. Notably, HIV care providers did not appear to be perceived as 
part of the government-pharmaceutical power complex. This suggests that while many people 
may endorse these types of ideas, endorsement does not necessarily directly impact engagement 
in care. However, endorsing positive beliefs about the efficacy of ART, and the belief that HIV 
can be a chronic disease if treated consistently, helped participants remain adherent or desire to 
re-commit to taking it consistently. Participants also appreciated, and desired, providers that 
engaged in patient-centered medicine.  
Recommendations:  
It may be that public health does not necessarily need to endeavor to dislodge origin or 
pharmaceutical/cure-related beliefs; rather, interventions can focus on building trust between 
health care providers and populations that have been experienced both historically and ongoing 
marginalization. Participants’ emphasis on wanting to manage their ART-related challenges with 
	
	
their providers suggests that HIV providers have an instrumental role in not only lowering viral 
loads and achieving viral suppression, but also helping their patients feel agentic and able to 
manage their HIV. Implementing patient-centered medicine will also engender trust, thereby 
helping patients internalize the belief that consistent engagement and ART adherence makes HIV 
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The limitations of the Tuskegee study as a master attribution to medical mistrust: 
HIV as the prototypical illness for examining HIV-related beliefs 
 
Abstract 
Mistrust of health care systems and/or providers is thought to provide a partial 
explanation for why African Americans are less likely to access health care. The 
literature suggests that the Tuskegee Syphilis Study is largely responsible for this 
persistent mistrust. A particular type of mistrust, most commonly referred to as HIV-
related “conspiracy beliefs” in the literature and popular culture, is also primarily 
attributed to African American populations.  
These HIV-related beliefs have been explored in relation to birth control use, HIV 
testing, and participation in HIV-related biomedical research. More recently, the 
emphasis on treatment as prevention (TasP) for all people living with HIV has shifted the 
HIV-related “conspiracy belief” research to studies of engagement and ART adherence. 
However, the literature on HIV-related “conspiracy beliefs” and engagement and 
adherence is limited, and has provided equivocal findings that point to the need for 
further research on the relationship between these beliefs and going to clinic and/or 
adhering to ART.  
Further research should discontinue the use of the phrase “conspiracy beliefs” in 
favor of more precise terms that describe people’s beliefs in a less judgmental and 
discrediting way. For example, referring to these ideas as origin- or treatment-related 
beliefs describes the nature of the ideas, and leaves rhetorical space for thinking about 
possible reasons why people endorse them. Related, the almost singular focus on the 
Tuskegee study as the source for ongoing medical mistrust among African Americans 
(and other minority populations) requires a critical appraisal, if we are to better 















Conceptualizations of the Term “Conspiracy Beliefs” 
Mistrust of health care systems and/or providers is thought to provide a partial 
explanation for why African Americans are less likely to access health care [1-3]. Most 
of the literature on medical mistrust pertains to interpersonal trust between physicians and 
patients [4-6], although some studies explore trust in healthcare systems, hospitals and 
health insurers [7-8]. Medical mistrust may also be illness-specific (e.g., HIV or vaccine-
related suspicion, or mistrust of new reproductive methods) or pertain in general to 
mistrust of and reluctance to participate in biomedical research. Moreover, the literature 
suggests mistrust is not merely the opposite of trust; rather, mistrust is more negative than 
the absence of trust and it refers to the belief that the entity that is the object of mistrust, 
is acting against one’s best interest and well-being [9,10].  
Among racial and ethnic minority groups in particular, the medical mistrust 
literature also encompasses research on “conspiracy beliefs.” “Conspiracy” theories and 
beliefs are found throughout society, and pertain to a wide range of social phenomena, 
including HIV.  A conspiracy theory, by definition, is a set of beliefs or theory of a 
“proposed plot by powerful people working together in secret to accomplish some 
(usually sinister) goal” [11,12]. Conspiracy theories most typically highlight perceived or 
actual power differentials between higher status and lower status groups. Interestingly, 
they “are not by definition false; indeed, many real conspiracies have come to light over 
the years” [12]. For example, the US federal government recently admitted the existence 
of Area 51 in Nevada, confirming a decades-long conspiracy theory that was previously 
vehemently denied by the military. Although the government only admitted to a portion 




extraterrestrial beings -- the confirmation of Area 51 was still a victory and serves as a 
validation for many other “conspiracy” theories [13]. Moreover, “conspiracy beliefs”, 
“even when wrong, are notoriously resistant to falsification…with new layers of 
conspiracy being added to rationalize each new piece of disconfirming evidence.” [12] 
Thus, the nature of “conspiracy beliefs” make it difficult to persuasively present evidence 
to refute or prove them, especially in light of how such theories are sometimes eventually 
found to be true or at least partially accurate.  
Despite their nebulous nature, “conspiracy beliefs” have a very real public health 
impact. For instance, while polio has been considered nearly eradicated worldwide, it is 
emerging again in Pakistan and Somalia. At the heart of this resurgence are “conspiracy 
beliefs”; that is, in Pakistan and other Muslim countries, public health efforts to vaccinate 
against the disease have been impeded by widespread rumors that the vaccine sterilizes 
girls, or contains pork products or even the virus that causes AIDS [13]. In the case of 
polio, opposition to the vaccine is not specifically related to HIV, but there seems to be a 
constellation of beliefs that link the polio vaccine to acquiring other diseases, including 
HIV. This suggests how people, faced with structural, health-related barriers such as 
poverty, disease and other forms of disenfranchisement (e.g., conflict, economic 
marginalization) may link pre-existing health-related fears (e.g., sterilization of the poor, 
HIV as a form of genocide for the poor or racial/ethnic or religious minorities) to newly 
introduced health policies or interventions. 
Locating the phenomenon in a racialized context, Waters (1997) notes 
“conspiracy theories held by African Americans that seek to explain ethnic inequality are 




of tremendous uncertainty in interethnic relations. In addition, they may shape behavior 
by providing parameters for political and social action in racial conflicts. In short, 
conspiracy theories express deep-running ethnic tensions while they influence the 
directions of interethnic interaction.” [14] In this sense, Waters’ analysis suggests that 
“conspiracy beliefs” held by African Americans may represent manifestations of the 
various ways in which society is shaped by rigid, interlocking structures of racism, 
sexism and classism.   
Similarly, Mackenzie posits that “conspiracy beliefs” should be viewed as 
“counter-narratives” to understand how people’s experiences may be both embodied, and 
reflective of a particular cultural understanding. Further, she argues counter-narratives 
“create a rhetorical space for challenges to power through the articulation of oppositional 
ideas about dominant scientific knowledge.” [15] Therefore, health-related “conspiracy 
beliefs” can been seen as collective stories generated by socioeconomically and 
symbolically marginalized groups that attempt to discredit, if not resist, the dominant 
biomedical discourse.   
Similarly Heller (2015) argues that HIV-related “conspiracy beliefs” are not in 
fact ignorance, but rather can be understood as: 1) the "result of historical experiences 
that have engendered distrust, 2) a result of continuing distrust, and 3) an indication of 
social anxieties associated with the HIV/AIDS epidemic, drug use (as a source of HIV 
infection and as an arm of the genocide attempt), and African American's place in 
American society" [16].  In this sense, such beliefs are a “measure of trust” between 
African American communities and the health care system. In contrast to other studies 




that increased knowledge will “work only if people trust the sources of official 
information", which are often government agencies such as CDC, or local city and state 
health departments [16]. Although the public health literature conceptualizes “conspiracy 
beliefs” as a type of mistrust, the literature largely lacks the nuanced view that Heller 
proposes and instead overly relies on the Tuskegee syphilis study narrative to explain the 
phenomenon. 
 
The Tuskegee Experience as a Master Attribution of “Conspiracy Beliefs” 
The widespread focus on “conspiracy beliefs” as a cultural characteristic of the 
African-American population in the United States is largely explained by the literature’s 
emphasis on the Tuskegee study as a catalyst for such ideas and beliefs.  Health research 
has for the most part taken the position that the origins of “conspiracy beliefs” are deeply 
rooted in the historical-institutional racism that characterized the era of slavery, and was 
later reflected in the infamous Tuskegee study [17,18]. The study, conducted by the 
Public Health Service and largely considered one of the most egregious abuses of 
research participants in public health history, conducted syphilis experiments on socially 
marginalized Black men from 1932 to 1972, and withheld penicillin to assess the long 
term effects of syphilis on the body when left untreated [19]. In both the fields of public 
health and popular culture, including the media, the study is frequently cited as a key 
contributor to medical distrust among racial/ethnic minority populations [18,20,25]. The 
emphasis, however, is on the Tuskegee study. The almost singular focus on this particular 
study as the source for ongoing medical mistrust and “conspiracy beliefs” among African 




mistrust manifests itself in relation to health beliefs and behaviors and how to address its 
deleterious effects on health care seeking and engagement in care [20].  
The enduring focus on the Tuskegee study perhaps obscures more recent 
examples of research misconduct or instances of racism in research and medicine, which 
range from unethical practices in pharmaceutical trials to coercive sterilization of Native 
American and Puerto Rican women [22-24]. It is possible that the continued emphasis on 
Tuskegee, as a symbol of past racism in medical research, prevents a more nuanced 
understanding of how ongoing racism, compounded by historical racism, affects trust and 
mistrust among populations of color in the United States.  I assert that the gravity of the 
Tuskegee abuse prohibits public health from discerning new ways in which experiences 
of racism affect the trust or lack thereof people of color have towards the rapidly 
changing field of biomedicine and new emerging diseases, such as HIV, Ebola, or 
antibiotic resistant infections. Labeling the collective beliefs and stories that reflect this 
lack of trust or mistrust of people of color towards the field of biomedicine “conspiracy 
beliefs” discredits them, and this is why in this literature review I elected to place this 
phrase in quotation marks.    
Many historians and public health researchers have critically analyzed various 
aspects of this infamous study [20, 25-27]. There is disagreement about the extent of the 
impact of the Tuskegee study on the African American population’s distrust of the health 
care system.  Some studies have offered the Tuskegee study as a primary cause 
underlying health-related mistrust, but some empirical investigations have tested this 
association and concluded that the study has less of a clear explanatory power.  For 




Baltimore, MD revealed that although there were no significant racial differences 
regarding Tuskegee knowledge, Black participants expressed higher levels of mistrust 
toward medical care than their white counterparts [19]. This difference in health-related 
mistrust became evident when participants who were previously unaware of the Tuskegee 
study were made aware, and were subsequently asked if they believed a similar event 
could occur today. Among white participants previously unaware of the study, 63.6% 
reported that they believed a similar study could happen today, versus 37.5% that had 
previous knowledge. Thus, for white participants, becoming aware of Tuskegee 
significantly increased the belief that similar abuses could occur today. However, for 
Black participants previously unaware of the study, 76.9% indicated that similar abuses 
can occur today whereas this belief was expressed by 87% of those that had demonstrated 
previous knowledge of the study. Several inferences can be drawn from these findings. 
First, becoming aware of the Tuskegee study increased white participants’ belief in 
biomedical abuses to a far greater extent compared to whites who were already aware of 
this abuse. This suggests that the white participants who had contended with the 
Tuskegee abuse seem to perceive a historical distance between the past and the present 
and are optimistic that such abuses are less likely to occur in the present. However, this 
did not seem to be the experience of the Black participants since the overwhelming 
majority of those who knew of Tuskegee indicated that it was very possible that similar 
abuses can occur in the present. These participants, unlike their white counterparts, did 
not draw a sharp distinction between the past and the present and thus indirectly 
expressed a distrust of the current systems and policies to prevent biomedical abuses. 




study, a very high percent of Black participant endorsed the belief that biomedical abuses 
are possible even today. These differences suggest that Tuskegee becomes integrated in 
the collective consciousness of Black communities in different ways compared to whites, 
and that the health-related mistrust among African Americans is shaped not only by 
historical events, but also by lowered expectations of health care quality based on 
ongoing experiences of racism and social exclusion.  
A 2009 study by Katz and colleagues found that specific knowledge of the 
Tuskegee study (TSS) was low among a sample of African Americans, Puerto Ricans, 
and non-Hispanic whites [28]. The telephone survey was administered to 1,162 adults in 
Baltimore, MD, San Juan, PR, and New York City. The authors found that 89% or more 
of African American, Puerto Rican, and white participants were not able to “name or 
definitely identify” the Tuskegee study when presented with study attributes. Of the three 
racial/ethnic groups, African Americans were the most likely to identify the Tuskegee 
study without being given a probe (11.5% of African Americans, versus 6.3% of Puerto 
Ricans, and 1.9% whites). When participants were given a probe, 37.1% of African 
Americans “clearly identified” the study, 26.9% whites, and 8.6% for Puerto Ricans. The 
authors conclude that is it unlikely that specific knowledge of the Tuskegee study has 
“any current widespread influence” on minority people’s willingness to participant in 
biomedical research and they advise health disparity researchers to refrain from assuming 
that community leaders’ knowledge matches that of community members. They note, 
“these data clearly show then that most people do not have recall memory about, much 
less routinely think about, the TSS when asked about incidents of medical research 




explaining medical mistrust, it is important to note that specific knowledge of the 
Tuskegee study- such as details of the study regarding location, dates, or particular 
violations is not necessarily needed for an individual or community to mistrust the health 
care system, avoid participation in clinical research, or endorse “conspiracy beliefs.” An 
alternative interpretation of the data could suggest that people may be generally aware of 
instances of medical abuses, particularly in the context of racism, without widespread 
knowledge of particular details.  
Mays et al. (2012) conducted a telephone survey in Los Angeles to assess the 
relationship between Tuskegee-specific knowledge levels among 510 African Americans 
and 253 Latinos and HIV-related “conspiracy theories” [29]. Consistent with previous 
literature on the prevalence of such beliefs among African Americans and Latinos, this 
study also found that African Americans were significantly more likely to endorse 
“conspiracy theories” than their Latino counterparts. Lower income levels and lower HIV 
knowledge were also predictors of endorsement. Although 72% of African Americans 
and 94% of Latinos reported that they had never heard of the study, the former group 
reported more Tuskegee-specific awareness. The authors conclude that while Tuskegee 
awareness was a significant predictor of endorsing HIV-related “conspiracy theories”, 
there are other factors that likely contribute to low biomedical research participation rates 
among African Americans, including low levels of knowledge about HIV, and fears of 
exploitation during clinical trials. They concluded that the syphilis study alone is an 
inadequate explanation for medical mistrust and “conspiracy beliefs” among African 
Americans [29]. The findings of the above studies are important because they 




Americans’ health-related mistrust.  
 
HIV-related “Conspiracy Beliefs” in the Public Health Literature: the Epidemic of HIV 
and its Relationship to “Conspiracy Beliefs” 
HIV-related “conspiracy beliefs” center around the notion that the U.S. federal 
government has been involved in creating and/or maintaining HIV/AIDS as a form of 
genocide against African Americans and/or other minority populations, such as racial and 
ethnic minority groups [30,31], and possibly men who have sex with men (MSM) and 
drug users. Similarly, these theories also refer to beliefs that antiretroviral therapies 
(ART) are used to experiment upon, and/or kill those with HIV-infection who take them, 
or that a cure is available but is being secretly withheld by the government and/or 
pharmaceutical companies in order to further marginalize or exterminate “minority” 
groups and profit from the sales of antiretroviral medication, respectively [30,31]. 
Although "conspiracy beliefs" exist in other areas of health and society, HIV 
exceptionalism likely contributes to the longevity and durability of HIV-related ideas 
[32,33].  The relatively recent emergence of the disease, and the initial uncertainty 
regarding its modes of transmission, solidified its association with marginalized groups 
engaged in lifestyles stigmatized as alien if not perverse [34]. Initially, HIV was 
associated with gay men, and later, post-GRID, racial and ethnic minorities, substance 
users and sex workers. The persistent discourse concerning the African origin of HIV has 
also likely shaped the nature of "conspiracy beliefs."  Its enduring disproportionate effect 
on racial, ethnic, class and sexual minority populations in particular-both in the United 




linked to pervasive social inequalities [35,36]. Moreover, the intense stigmatization of 
HIV-infected individuals that were already stigmatized and discredited because of their 
lifestyle (e.g., MSM or substance users) has the potential to further marginalize and 
exclude them from social, economic and symbolic resources. This systemic, ongoing 
alienation constitutes fertile ground for the preservation of HIV-related “conspiracy 
beliefs.” Therefore, despite advances in biomedicine with regard to HIV, these beliefs 
remain a part of the illness representation and public health remains interested in 
examining their association with the epidemiology of the disease. This HIV treatment 
success explains the public health focus on linking and retaining in care and treating with 
ART all PLWH; treatment as prevention (TasP) has become the most recent message for 
ending the epidemic. Therefore, “conspiracy beliefs”, most recently, are being examined 
in relation to engagement in care, as discussed in the next section.    
 
Engagement in HIV Care and ART Adherence 
Recommendations regarding the HIV care continuum currently focus on 
treatment as prevention (TasP) [37,38]. The shift from defining HIV prevention as HIV 
testing has shifted very deliberately to the role of consistent ART adherence as a primary 
strategy to achieve viral suppression, thus not only reducing the risk of transmission of 
HIV to others, but also decreasing morbidity and mortality [39,40].  Thus, the trend in 
HIV prevention has drastically shifted the focus from solely or primarily linking 
individuals to HIV testing, to linking, engaging, and retaining PLWH in consistent 
outpatient HIV care thus ensuring ART adherence. This treatment cascade includes 




load and CD4 count, as well as PrEP (pre-exposure prophylaxis) to those who are 
uninfected but engage in high-risk behaviors [37]. Reflecting this trend, research on HIV-
related “conspiracy beliefs” has followed suit and has attempted to account for the role of 
such ideas in the engagement and adherence-related behaviors of people who are socially 
marginalized. HIV-related “conspiracy beliefs” are associated with primarily low-income 
people of color, particularly African Americans [43-45]. Thus, it makes sense that 
research trying to explain the impact of these beliefs has focused on these same 
populations, given that socially and economically marginalized groups are more likely to 
be linked later, poorly retained, and struggle with consistent ART adherence [46-48].  
HIV-related “conspiracy beliefs” have been widely documented in the public 
health literature as affecting a variety of health practices and outcomes, including those 
related to HIV testing [49,50], birth control and condom use [51,52], HIV vaccines 
[53,54], and participation in HIV-related clinical research [55,56] as they expose fears 
about reproductive rights violations and genocide [15].  More recently, some work has 
been done on the relationship between such beliefs and engagement in HIV care and/or 
ART adherence. However, there is substantially less literature exploring this relationship, 
and the findings of the limited literature that does exist are mixed in regard to whether or 
not endorsing such beliefs negatively affects engagement and/or adherence [57-60]. 
In a 2008 cross-sectional investigation, Clark et al. [57] examined the prevalence 
of “conspiracy beliefs” among 113 patients engaged in care at four public facilities in 
Houston, Texas. Using five items that addressed the origin of HIV, and a cure and 
vaccine for HIV, they found that 63% of the participants endorsed one or more 




likely than white and other/multiple race patients to hold such beliefs (however, non-
Black participants also endorsed such ideas). Those endorsing the beliefs had higher CD4 
counts at diagnosis, and higher current counts. Moreover, the presence of “conspiracy 
beliefs” among HIV-positive patients was not associated with a delay in diagnosis or 
ART adherence. However, they did not specifically look at each racial/ethnic group 
separately, and noted that the study’s recruitment focused on patients engaged in care, 
and thus did not necessarily represent people living with HIV/AIDS (PLWHA) with more 
extreme or deeply held “conspiracy beliefs” that do not interact with the healthcare 
system around their HIV illness. This suggests that further research is needed to better 
understand how “conspiracy beliefs” may affect how people who are out of care think 
about HIV and manage their illness, including whether these beliefs prevent them from 
engaging with care, or influence non-adherence.  In particular, Clark and colleagues 
suggest the prevalence of “conspiracy beliefs” may increase over time, perhaps due to 
increased interactions with other PLWH, experiences with medication side effects, or 
HIV-related stigma, both felt and enacted.   The authors conclude that trust/mistrust in 
one’s provider may not be correlated with trust/or mistrust in the government, and that 
further research is needed to examine if provider trust is more important in terms of 
influencing health-related behaviors. They recommend that since patients are able to 
distinguish between their beliefs about the origin and treatment of HIV and their need for 
medical care, health care providers should endeavor to build more trusting relationships. 
Importantly, they did not find that educational level was a predictor for “conspiracy 
beliefs”, thus suggesting that education/awareness-oriented interventions are not the most 




A 2010 study by Bogart and colleagues on HIV-related “conspiracy beliefs” and 
adherence found that such beliefs were associated with ART non-adherence among 
African American men engaged in HIV care in Los Angeles, CA [58]. The baseline 
included 214 men, and 177 returned for follow up. “Conspiracy beliefs” were 
operationalized using two distinct sub-scales: 1) genocide-related beliefs, and 2) 
treatment-related beliefs. Genocide-related beliefs items included, “HIV is a manmade 
virus”, “AIDS was produced in a government laboratory”, and “AIDS was created by the 
government to control the Black population.” Treatment-related items included, “People 
who take the new medications for HIV are human guinea pigs for the government”, and 
“The medicine that doctors prescribe to treat HIV is poison.” 
In bivariate tests, both sub-scales were associated with non-adherence; however, 
in a multivariate logistic regression, only treatment-related “conspiracy beliefs” were 
related to a lower probability of optimal adherence at the one-month follow-up. These 
findings suggest that different HIV-related “conspiracy beliefs” may have distinct 
dimensions that must be examined individually for identifying their association with 
different health practices (e.g., attending visits vs. adhering to treatment) and dispositions 
(e.g., AIDS was created by the government in the laboratory vs. ART is poison). The 
authors recommend interventions to “address culturally specific roots of non-adherence 
to overcome medical mistrust”, such as using peer treatment advocates who “understand 
cultural barriers” to adherence, and encouraging providers to be open to dialogue about 
patient’s ART-related concerns. Importantly, they note that these kinds of beliefs cannot 
simply be dismissed as “rare or extreme”, given the high prevalence among Black 




American communities to identify sources of both “accurate and inaccurate” HIV 
information (Bogart and colleagues provide this research in 2016, see below).  Like the 
Clark et al. study (2008), this study also exclusively sampled individuals engaged in care, 
thus suggesting again that research is needed to explore how “conspiracy beliefs” may 
affect how disengaged people, who we can hypothesize might be more disenfranchised, 
think about and utilize care. Additionally, while the Bogart et al. study innovatively 
explored two distinct dimensions within the broad category of HIV-related “conspiracy 
beliefs”, thus providing a more nuanced understanding of the different ways in which 
certain types of beliefs can affect particular aspects of health behavior, the items 
conflated the role of the government in the epidemic and the role of providers in 
prescribing toxic medication. Future research on this topic should explore people’s 
beliefs about the government and health care providers as separate entities in order to 
allow participants to make these potential connections. 
A 2012 study by Beer and colleagues explored the relationship between accessing 
HIV medical care and what they termed health-related beliefs [59]. This qualitative 
investigation conducted focus groups in five US cities, nearly all of whom were African 
American, male and had not received HIV care in the previous six months.  The authors 
found that, among other barriers to care (such as negative experiences with providers), 
distrust of health care was a key factor in influencing people’s HIV engagement in care 
decisions. Although some participants had also reported trust issues related to past 
negative experiences with providers, participants also shared “generalized feelings of 
distrust of health-care related entities, which contributed to suspicions about 




pharmaceutical industry, and the “medical community as a whole”, which not only 
included pharmaceutical-related ideas, but also beliefs about the genocidal origin of HIV. 
This study also cites the Tuskegee study as an explanation for the health-related mistrust 
of people of color.  The authors recommend cultivating good patient-provider 
communication to help reduce mistrust. 	
In a recent systematic review of the literature pertaining to the associations 
between HIV-related “conspiracy beliefs” and HIV care, including treatment adherence, 
Gaston and colleagues (2013) concluded that three main factors affect engagement in 
care: 1) racism and discrimination within the health care system; 2) “conspiracy beliefs”; 
and 3) the quality of the patient-provider relationship [17]. Notably, the authors suggested 
that “conspiracy beliefs” possibly point to the “intergenerational transmission of medical 
mistrust.” This notion warrants further research, as it implicitly draws attention to the 
importance of ongoing racism, rather than discrete historical events, and of the role of 
providers in patients’ lives, including as a potentially countervailing force to “conspiracy 
beliefs” and discrimination in the medical system.  The authors suggest that having a high 
quality relationship with one’s provider can “serve as a protective factor”, and thus offer 
several recommendations directed at providers. These included encouraging providers to 
openly reflect on their own personal beliefs, perceptions and biases (and how they may 
affect treatment decisions), listen to patient narratives, enable patients to share in 
treatment decisions, and to expand their social networks to include more diverse people 
[17]. In doing so, providers can exercise reflexivity, and foster a transparent patient-
provider relationship where patients are comfortable sharing their ideas and beliefs 




Although the vast majority of the studies on HIV-related “conspiracy beliefs” 
examine the phenomenon among adult African Americans, Gillman and colleagues 
(2013) assessed the impact of “conspiracy beliefs” on linkage to care and retention in 
care among young MSM of color (ages 13-24) [59]. Recruited from a health center, 
participants were provided with services over a six-month follow up period.  As in 
previous work on HIV-related “conspiracy beliefs”, the authors assessed beliefs about 
government involvement in spread of HIV and the possibility that pharmaceutical 
companies or the government were withholding a cure that already existed. Fifty seven 
percent endorsed at least one “conspiracy belief”, and “conspiracy beliefs” were 
associated with negative medication attitudes. However, “conspiracy beliefs” were not 
correlated with CD4 count at time of diagnosis (suggestive of time from infection to 
testing), linkage to care or retention in care. Echoing the literature on provider trust, the 
study also found that trust in physicians was associated with positive medication 
attitudes. Ultimately, the authors concluded that “conspiracy beliefs” do not predict poor 
linkage and retention in care among this particular population, but noted that they did not 
assess medication adherence, and that participants received linkage, case management 
and clinical services, which may have offset any negative effects. They recommended 
additional research to elucidate the relationship between provider trust, trust in the health 
care system, attitudes toward medication, and adherence, particularly among MSM youth 
living with HIV.  
In a recently published study, Bogart and colleagues (2016) explored HIV-related 
“conspiracy beliefs” in the context of people’s social networks i.e., those closest to them, 




operationalized with the same genocidal- and treatment-related subscales used in Bogart 
et al 2010, described above. The authors assessed two main items among a sample of 175 
African Americans: 1) whether HIV-related “conspiracy beliefs” in social networks are 
associated with non-adherence of ART (using electronically monitored bottle caps), and 
2) the characteristics of individuals in their social networks who discuss these ideas (e.g., 
socio-demographic background, such as race and ethnicity and HIV status). HIV-related 
mistrust was operationalized as whether any social network member had ever discussed 
“conspiracy beliefs” with the participant.  The authors focused on social networks due to 
previous research suggesting that social network members are in a position to encourage 
or discourage healthful behaviors via communication of norms and modeling behavior. 
These assessments were performed at baseline, 6 months, and 12 months post-baseline. 
The authors found that 63% of participants endorsed at least one “conspiracy belief”, and 
55% had heard at least one social network member endorse such beliefs. Endorsement of 
“conspiracy beliefs” by members of their social networks was significantly associated 
with participants’ ART non-adherence. They also found that the expression of such 
beliefs was more likely among social network members who were also HIV positive, who 
were aware of the participant’s HIV status, and with whom the participant frequently 
interacted. Notably, the authors argued that previous studies that demonstrated null 
findings regarding the relationship between HIV-related “conspiracy beliefs” and ART 
adherence included groups other than or in addition to African Americans, and this make-
up of the sample may have been obscured or attenuated the relationship between African 
Americans endorsing these beliefs and non-adherence. The authors broadly suggest that 




wider historical and present context of structural discrimination in health care and other 
societal institutions.” Specifically, they offer provider-focused recommendations, such as 
making providers aware of “the historical context of discrimination” that may be 
influencing the health behaviors of African Americans, as well as the prevalence of 
mistrust in patients’ social networks. For example, in “cultural competency trainings”, 
providers could “be educated about the historical context in which African American 
patients are approaching healthcare and medical research”, and receive training in 
motivational interviewing to “proactively stem such beliefs in a non-confrontational, 
empathetic fashion” [60].   
 
Discussion  
Although studies on the relationship between “conspiracy beliefs” and health, 
particularly HIV, have been deliberate in their critical examinations of historical abuses, 
the term “conspiracy belief” oversimplifies the complexity of the status quo social and 
health inequalities that are deeply rooted in not only historical, but also ongoing social 
injustice. This oversimplification is particularly evident in the excessive emphasis on the 
Tuskegee narrative as a dominant explanation for such mistrust. Moreover, relying on 
this explanation implies that other populations of color do not have these beliefs, and/or 
have not experienced other kinds of medical research abuse, or more broadly, persistent 
social and economic exclusion.  
Previous literature on HIV-related “conspiracy beliefs” and engagement and 
adherence has provided equivocal findings that point to the need for further research on 




By reframing “conspiracy beliefs”, and exploring the reasons underlying their existence 
(as well as the possible purposes they may serve for the individual and group), we may be 
better able to address the role of “conspiracy beliefs” in affecting health behaviors and 
outcomes. Thus, moving away from the phrase “conspiracy beliefs” could help re-frame 
how we understand not only historical, but also ongoing structural inequality as a 
fundamental cause of social and health inequalities.  
First, the word “conspiracy” connotes irrational and paranoid, or even dangerous. 
Popular culture links this word to a range of social phenomena, from aliens and Area 51, 
to ideas and theories about the events of September 11, 2001 [61]. Using this phrase to 
refer to how people think about and experience social inequality is ultimately alienating 
and discrediting. For example, this uncritical phrase enables the researcher or health care 
provider to describe certain ideas, beliefs and experiences in ways that discredit them, 
and excludes the persons or groups that may express them and thus be able to provide a 
grounded description or definition. If researchers and providers dismiss or characterize 
patients’ beliefs as paranoid instead of stemming from their sociocultural experiences, 
they may engage with them in a particular way that is perhaps patronizing instead of 
patient centered.  
Moreover, this phrase has been used in public health to define and 
problematically point to notions of “culture,” rather than structure, thus reinforcing the 
problematic notion that racial and ethnic minority groups possess an inherently deficient 
set of values, norms and beliefs that ultimately contributes to their health disparities.  
Therefore, a monolithic focus of culture divorced by structural conditions that generate it 




behavior. When these ideas are described as “cultural barriers,” the message is both 
dangerous and misleading, similar to how cultural competence is broadly critiqued for 
suggesting a tangible set of knowledge - reified in a cultural “checklist” of sorts, where 
providers are taught to memorize supposed cultural attributes and stereotypical traits of 
different racial and ethnic groups [62,63]. The concept of “structural competency” that 
calls for clinicians to understand and integrate into their practice the structural and 
institutional factors that influence the lives and disposition toward their health of their 
socially marginalized patients is a step in the right direction and, certainly, moves the 
field beyond the dangerous concept of cultural competency [68,69]. 	
Here, it is important to push the boundaries of these dominant public health 
understandings of “conspiracy beliefs” to try to achieve a significantly more complex 
examination of past and ongoing racism, with a particularly focus on how historical 
injustice continues to affect interpersonal, institutional and structural phenomena. 
Although public health has explicitly aimed to reduce the prevalence of HIV-related 
“conspiracy beliefs”, it is important to consider that such ideas may constitute a form of 
resistance (direct challenge, deflection, avoidance) to past and ongoing injustice and 
trauma [15]. Thus, holding such beliefs, and even more so expressing them, may serve in 
some ways as a protective factor against pervasive racism, discrimination and perhaps 
stigma in the health care system and more broadly, a society hierarchically structured 
based on status.  
Undoubtedly, not engaging in HIV care is associated with adverse health 
consequences and therefore is not adaptive in terms of preserving and promoting one’s 




(i.e., a behavior that may be protective in some ways and detrimental to health in other 
ways) [64]. For people living with HIV that tend to be socioeconomically powerless and 
that occupy the lower ranks of a social hierarchy that is inherently marginalizing, 
embracing these “counter-narratives” may be a form of asserting symbolic power [15].  
This perspective opens up the space to examine whether endorsing such beliefs fulfills a 
need to feel that one has some control over one’s life and illness, if only through having 
control over the narrative they make about their illness. That is, fashioning a story about 
one’s illness that discredits the dominant biomedical story is a way of exercising 
symbolic power and this might have psychological advantages, despite producing 
negative physical consequences. In this sense, holding “conspiracy beliefs” may also be 
an example of exercising agency and/or resisting dominant power structures, even though 
this exercise of agency may, at least in part, have some negative impacts on one’s 
wellbeing, family and community. Thus, the literature’s recommendations to “educate” 
people in order to dislodge these beliefs serve to highlight the lack of a full understanding 
of how these ideas may play a role in people’s lives.  
 
Recommendations  
Interrogating and refining the concept of “conspiracy beliefs” as conceptualized in 
public health allows us to practice reflexivity about the ways in which discourse and the 
production of knowledge are mutually constitutive and situated in a specific professional, 
cultural, political and historical context [65].  The phrase “conspiracy beliefs” risks 
obscuring, discrediting or even erasing the nuances of people’s lived experiences; by 




opportunities to better understand the thought processes and experiences of the 
populations with whom we work and serve. Although social determinants models can 
contribute to helping researchers and public health practitioners understand the impact of 
population-level material inequality on health outcomes [66], a more critical approach is 
needed that considers how people, as individuals, but also as members of groups, 
experience and interpret social and economic exclusion and injustice. This approach 
necessitates discontinuing the use of the phrase “conspiracy beliefs” in favor of more 
precise terms that describe people’s beliefs in a less judgmental and discrediting way. For 
example, referring to these ideas as origin- or treatment-related beliefs describes the 
nature of the beliefs, and leaves rhetorical space for thinking about possible reasons why 
people endorse them. 
 Moreover, a qualitative examination that invites persons with HIV to describe 
their ideas and beliefs about the illness and its treatment without limiting their accounts to 
pre-determined or pre-defined explanations of its origin or beliefs about ART can refine 
the conceptualization of these kinds of ideas and their relationship to becoming involved 
with the healthcare system. A qualitative design could also explore in-depth socio-
economic aspects of these beliefs, as the literature predominantly focuses on race. 
Related, including in studies other persons of color, and not limiting samples to African 
Americans, also has the potential to enrich our understanding of this phenomenon and 
facilitate our moving beyond simplistic associations of health-related “conspiracy 
beliefs” with the Tuskegee study. Given the intersectional nature of people’s lived 
experiences, and the multiple layers of stigma experienced by PLWH, it would also be 
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Background: HIV-related “conspiracy beliefs” can include the ideas that the government 
created HIV to target specific minority groups, that antiretroviral medication is used to 
experiment on vulnerable groups, or that a cure is being withheld or delayed by 
pharmaceutical companies. In the United States, this phenomenon, usually framed as a 
type of medical mistrust, is largely attributed to populations of color, particularly African 
Americans. The public health literature strongly suggests that HIV-related “conspiracy 
beliefs” primarily stems from historical medical abuses targeting people of color, 
particularly the infamous Tuskegee Syphilis Study. Although many studies have assessed 
the prevalence of such beliefs, little is known about the possible relationship between 
endorsing these ideas and disengagement from HIV care among persons living with 
HIV/AIDS (PLWH). 
Methods: Over the course of one year, 27 semi-structured, in-depth interviews were 
conducted with low income PLWH of color living in the NYC area that are currently, or 
were recently, disengaged from outpatient HIV medical care. Additionally, a brief 
questionnaire was administered to obtain demographic and engagement/medication 
adherence data to describe the sample of participants. 
Findings: This analysis revealed the variation, texture and diversity related to people’s 
beliefs about the origin and treatment of HIV. In particular, beliefs about the 
pharmaceutical industry and the government highlighted both the racism and classism 
experienced by low income who belong to racial and ethnic minority groups. Notably, 
HIV care providers did not appear to be perceived as part of the government-
pharmaceutical power complex. This study suggests that while many people may endorse 
these types of ideas, endorsement does not necessarily directly impact engagement in 
care. 	
Recommendations:  
It may be that public health does not necessarily need to endeavor to dislodge origin or 
pharmaceutical/cure-related beliefs; rather, interventions can focus on building trust 
between health care providers and populations that have been experienced both 
historically and ongoing marginalization. Further research is needed to better understand 
how the constellation of barriers to care, including health institution- and provider-related 











Background and significance 
HIV-related “conspiracy beliefs” center around the notion that the U.S. federal 
government has been involved in creating and/or maintaining HIV/AIDS as a form of 
genocide against African Americans and/or other minority and marginalized populations, 
such as racial and ethnic minority groups, and possibly men who have sex with men 
(MSM) and drug users [1]. These ideas also refer to beliefs that anti-retroviral therapy 
(ART) is used to experiment upon, and/or kill those who take it, or that a cure is available 
but is being secretly withheld by the government and/or pharmaceutical companies to 
profit from the sales of ART medication [1,2].  
Broadly, “conspiracy beliefs” are found throughout society, and pertain to a wide 
range of social phenomena. A conspiracy theory, by definition, is the idea of a “proposed 
plot by powerful people working together in secret to accomplish some (usually sinister) 
goal.” [3,4] Conspiracy theories most typically highlight perceived or actual power 
differentials between higher status and lower status groups. Moreover, such ideas “are not 
by definition false; indeed, many real conspiracies have come to light over the years.” [4] 
These traits of such beliefs contribute to their durable nature, and provide a partial 
explanation for why these kinds of beliefs persist over time.  
 In the United States, the phenomenon of “conspiracy beliefs”, usually framed as a 
type of medical mistrust, is largely attributed to populations of color, particularly African 
Americans, and most frequently men. Although there is some US-based research on 
“conspiracy beliefs” among groups other than African Americans, such as Native 
Americans and Latinos [5,6], the vast majority of research focuses on Black Americans. 




beliefs”, including male gender, black identity and lower income [7], in addition to other 
studies that have also found such beliefs to be prevalent among African American men, 
and those with lower educational attainment [8,9].  
A sociological analysis of HIV-related “conspiracy beliefs” also provides a partial 
understanding for the persistence of these ideas among racial and ethnic minorities in 
particular. Waters’ (1997) work on “conspiracy beliefs” suggests that such beliefs held by 
African Americans may represent manifestations of the various ways in which society is 
shaped by rigid, interlocking structures of racism, sexism and classism. She notes, 
“conspiracy theories held by African Americans that seek to explain ethnic inequalities 
are intrinsically interesting as a subset of conspiracy theories because they may indicate 
areas of tremendous uncertainty in interethnic relations. In addition, they may shape 
behavior by providing parameters for political and social action in racial conflicts. In 
short, conspiracy theories express deep-running ethnic tensions while they influence the 
directions of interethnic interaction.” [10] Similarly, Mackenzie posits that these ideas 
should be viewed as “counter-narratives” to understand how people’s experiences may be 
both embodied, and reflective of a particular cultural understanding. Further, she argues 
counter-narratives “create a rhetorical space for challenges to power through the 
articulation of oppositional ideas about dominant scientific knowledge.” [11]. 
  
Methods 
Sample study population and recruitment 
This paper examines the accounts provided by HIV-positive individuals of color  -




regarding the origin of HIV and anti-retroviral treatment. Participants were recruited from 
a larger sample utilized in a previous study (entitled Bedside to Community, “B2C”) 
examining disengagement from outpatient HIV care among hospitalized HIV positive 
patients. To be eligible for the B2C study participants had to: 1) be age 21 or older; 2) 
self-identify as non-Hispanic Black or Hispanic (of any race); 3) self-identify as HIV-
positive; 4) be confirmed as HIV-positive based on medical records; 5) report having 
been diagnosed with HIV for at least two years; 6) be currently hospitalized in the 
CUMC Adult AIDS unit; 7) have their most recent CD4 cell count under 350 based on 
medical record; and 8) report that they have not seen any HIV outpatient clinician for at 
least 6 months (please see the appendix for a more detailed description of B2C eligibility 
criteria, including a revised operationalization of disengagement). 
At the end of their B2C interview, individuals were asked for permission to 
contact them in the future to possibly participate in a follow up study, and if in 
agreement, asked to provide one or ideally two to three different contacts (self, family, 
friend, etc.) to facilitate follow up communication. This information was recorded in the 
Permission to Contact form. Individuals who agreed to be contacted about subsequent 
studies, constituted the sampling frame for the study described here.  
From July 2015 to May 2016, interviews were conducted with a subset of the 
B2C sample, that is, a purposive sample of twenty-seven (N=27) PLWH who, at the time 
of the interview, were currently disengaged from outpatient HIV care, or had been 
disengaged within the previous one to three years.  
The majority of potential participants were contacted via telephone using contact 




successfully contacted (either via telephone or in person at bedside when hospitalized at 
CUMC), 27 agreed to participate in the study presented in this paper. Two individuals 
declined participation, citing lack of time. One participant agreed to participate but was 
found to be not mentally competent enough to provide consent, and the remaining three 
were reached via telephone, but then lost again when their numbers appeared to change 
or go out of service before an interview could be scheduled.  
Data collection  
In-depth qualitative interviews can generate novel insights by allowing study 
participants to express in an open-ended manner and in their own words and from their 
own perspectives their HIV-related beliefs. Another advantage of qualitative interviews is 
that they facilitate the identification of topics that although unanticipated by the 
researcher, emerge as salient in the participants’ accounts [12,13]. They also can facilitate 
the identification of associations among topics for participants. Given the sensitive nature 
of the topic of “conspiracy theories”, these features of qualitative interviewing honor the 
participants’ ways of thinking and expressing themselves. 
A semi-structured interview guide was developed to examine barriers to 
engagement in outpatient HIV care, as well as to explore ideas and beliefs about and 
reactions to “conspiracy beliefs”; it is noteworthy that this phrase was not used in the 
guide. In many cases, the topic of these beliefs arose spontaneously during the interview 
and was raised by participants themselves. Participants were also asked about their ideas 
regarding the possible origin of HIV, and the possibility of a cure. These questions were 
designed to elicit discussion around the commonly referred to set of beliefs identified and 




HIV and its treatment.  Interview topics also included questions about experiences with 
recent hospitalizations, housing circumstances, experiences with outpatient HIV care 
(including engagement and ART adherence), other barriers to stable living conditions 
and/or engagement in care and thoughts and beliefs about HIV/AIDS (please refer to the 
appendix for examples of interview guide questions). Interviews ranged from 25 minutes 
to two hours, with an average of 45 minutes. The briefer interviews were the result of 
participants becoming fatigued due to very poor health; hence, those hospitalized at the 
time of the interview tended to have shorter interviews. Prior to the in-depth qualitative 
interview, an interviewer-administered questionnaire (IAQ) was also completed. This 
five to eight minutes brief survey gathered demographic and health status information 
(e.g., current housing situation, employment/public assistance status, recent 
hospitalizations, or ART use status). Importantly, the IAQ did not assess so-called 
“conspiracy beliefs” in order to allow these ideas to emerge spontaneously and 
organically in the in-depth interview. Although there are mistrust and “conspiracy belief” 
scales [14-16], we were interested in allowing participants to articulate their ideas in their 
own words and therefore elected not to administer these scales in the IAQ. 
In this study, engagement and ART adherence were assessed first in an 
interviewer-administered questionnaire (IAQ), and afterward discussed in-depth in semi-
structured interviews. The IAQ and the qualitative interview operationalized 
engagement/disengagement and adherence/non-adherence differently. The IAQ assessed 
engagement and adherence with items that asked participants about any outpatient HIV 
care they had received in the prior 12 and six months, including scheduled but missed 




adherence was assessed with items asking participants if they were currently taking ART 
at the time of the interview, if the ART was taken as directed, and intentions to begin, or 
to continue taking, ART in the next six months.  Qualitatively, participants could be 
classified as consistently engaged, inconsistently engaged, or disengaged. The 
“consistently engaged and adherent” category indicated uninterrupted engagement and 
adherence over a period of at least the past 6 months. “Inconsistently engaged” was a 
broader, descriptive category that included the following: (1) participants had only very 
recently re-established care, for example, a few weeks prior to the interview, but not long 
enough to establish a pattern of behavior; (2) participants were taking their ART 
consistently, but had frequently missed their HIV scheduled appointments in the past 6 
months; (3) participants were attending their HIV scheduled appointments regularly in 
the past 6 month, but had not been able to consistently take their ART as directed. The 
category of “disengaged” indicated participants that were not attending clinic and not 
taking their ART consistently (i.e., on schedule and as directed). Most participants were 
classified as “inconsistently engaged” (n =9), 7 were disengaged, and 11 were 
consistently engaged based on the qualitative assessment.  
 
Data analysis 
All interviews were audio recorded for professional transcription. Approximately 
20% of the transcriptions were randomly selected for quality control/accuracy that was 
conducted by the author. Qualitative analysis necessitates the development of a rigorous 
and organized method of managing and analyzing a rich set of textual data while keeping 




compromise the data’s conceptual richness and complexity. The author implemented 
multi-step method of conducting an analysis to systematically identify and contextualize 
the themes present in the data. This included developing a coding scheme, applying it to 
the data, and using it to discern patterns, themes and subcategories. The scheme was a 
hierarchically organized tool that ranged from the general and abstract to the more 
specific. At the top of this hierarchy, the author identified the analytic foci (coded as 
headings), next the core codes (that refer to specific aspects or dimensions of the 
headings), and last, sub-codes (that refer to specific aspects or dimensions of the core 
codes). An example of a core code is “pharmaceutical-related beliefs,” as defined by 
participants, and examples of related to this code subcodes are: “believes a cure is being 
withheld by the pharmaceutical industry” or “the pharmaceutical industry is big 
business.” After all transcripts were coded, text segments organized by codes/subcodes 
were extracted and closely read in order to begin identifying higher level of abstraction in 
regard to themes, and to also discern the relationship among codes. For instance, the 
codes and subcodes applied to segments of text where participants discussed the role of 
the government in the AIDS epidemic and the role of the pharmaceuticals and how they 
both benefitted from maintaining the epidemic revealed the similarities between these 
two power entities. This realization led to the inference that both government and the 
pharmaceutical industry constituted “conspirators.” Similarly, the codes and subcodes 
applied to segment of text where participants discussed that the patients who are low SES 
and people of color do not or will not have access to the cure for HIV elicited their 
understanding of who are the “target of conspiracy.” The next analytic step was to define 




conspiracy. The software Atlas.ti was used to organize the qualitative data. Data from the 
Interviewer-administered questionnaire data were analyzed using SPSS and used to 
generate a description of the sample of participants.   
 
Results 
Quantitative findings  
Of the 27 participants, 59% were female (n=16), 41% male (n=11), 78% Non-
Hispanic Black (n=21) and 22% Latino (n=6). Participant age ranged from 28-55. Asked 
about their housing circumstances over the past year, 74% of the sample reported living 
in an apartment, SRO or room supported by public assistance and/or HASA (n=20).  
One hundred percent of the participants had Medicaid; two participants had both 
Medicaid and Medicare. Most (89%) reported being unemployed at the time of the 
interview (n=24), one person was employed part-time, and two were employed full time. 
Participants could select more than one answer to describe their main reasons for being 
unemployed and therefore, the percentages below add up to more than 100. Specifically, 
74% reported that they were unable to have a full time job due to not feeling well enough 
(n=20); 37% were not sure if they will stay well enough to keep a job (n=10); 33% were 
fearful of losing medical benefits or other benefits if they worked (n=9); and 8% reported 
having to care for someone else (e.g., ill family member, or children) (n=2).  
Using a 12-month interval, we found that 78% had visited a doctor or clinic for 
HIV care at least once (n=21), and 70% (n=19) reported having been to two or more 
scheduled medical visits at an HIV outpatient clinic and these visits were separated by at 




examined by an HIV care provider (n=20); of these, 77% reported having missed at least 
one scheduled appointment (n=17); finally, 81% (n=22) reported being currently on HIV 
medication at the time of the interview. 
 
Table 1   
Participants’ characteristics  N 
Gender Female 16 (59%) 
 Male 11 (41%) 
Race / Ethnicity Black Non-Hispanic 21 (78%) 
 Hispanic /Latino 6 (22%) 
Housing Situation* HASA or public assistance (apt or room) 18 (67%) 
 SRO 7 (26%) 
 No financial assistance Nursing home or hospice 
2 (7%) 
3 (11%) 














 Medicaid + Medicare 2 (7%) 
ER use past 6 months Yes 19 (70%) 
 No 8 (30%) 
Attended HIV care past 12 months Yes 21 (78%) 
 No 6 (22%) 
Attended HIV care past 6 months Yes 20 (74%) 
 No 7 (26%) 
Attended ≥ 2 HIV visits past 12 months Yes 19 (70%) 
 No 8 (30%) 
Currently taking ART Yes 22 (81%) 





Theme 1: Beliefs related to the origin of HIV/AIDS 
 Consistent with the literature on the types of common beliefs held by minority 
individuals regarding the origin of HIV, many participants in this study also believed that 




other countries’ governments). Some participants believed that HIV was created with the 
sole intention of eliminating certain segments of the population, particularly racial and 
ethnic minorities, but also drug users and gay men. Others, however, strongly rejected 
such ideas, although they acknowledged the racism and powerlessness of racial minority 
groups and how these forms of social exclusion supported the ideas we tend to call 
“conspiracy beliefs.”  
    
HIV is a “manmade” virus intended to be genocidal  
The idea that HIV was deliberately created to kill minority people, particularly 
racial and ethnic minority groups and also substance users and gay people, was prevalent 
among the participants. For example, Aliyah, a 28-year old Black woman, was born with 
HIV and was inconsistently attending HIV outpatient care at the time of the interview, 
but had been consistently adherent to her HIV medication (one pill a day for the last 
year). Over the six months prior to the interview, she was hospitalized six times for what 
she described as “potassium-related” issues. She had been recently transitioned from the 
pediatric HIV clinic to the adult clinic, and perceived this change as a coerced transition 
that she did not wish to make. Below, she explained why she believed HIV was 
developed to specifically “kill off Black people”: 
 
Basically I truly believe that HIV was manmade.  It was made in a laboratory.  I think 
how it first got out was with those free shots that they was giving everybody, like free flu 
shots, free measles shots, free this shots.  Yeah, that’s what I truly believe, but I try to 
keep stuff like that to myself cuz it upsets people…  It was basically designed to kill off 
Black people.  There was too many of us and that’s what they wanted to do…when it first 
came out I did like a whole bunch of research.  When it first came out a whole bunch of 
people just were like dying like right after they got it and they try to basically blame it—
like the government trying to blame it on—what was it, like a monkey or gorilla or 




was a whole bunch of stuff going on in the 80s.  I basically just felt like that’s what they 
wanted to do, just take out a whole bunch of Black people cuz that’s what I saw.  When 
you look up HIV that’s what you basically see.  You see people in Africa and stuff like 
that…I’ve seen all the numbers.  [It’s] not [that] mostly Black people have it, but there’s 
a lot of us that do have it …That’s why I felt like it was created just to take us out…I 
mean anything is possible with the government because they say they have to… they have 
to tell us everything, but most of the time we don’t know what’s going on.  That’s why I 
really think that it was just—it was created just to take as many poor Black people out of 
the—off of the earth… Then they didn’t account for some of the White people who do like 
Black people and then mingling with the white folks and now they got it too. [Aliyah] 
 
Keira, a 41 year old Black woman, was hospitalized for PCP pneumonia at the time of the 
interview. Keira was diagnosed in 1997, and reported having begun ART again 
approximately a year prior to the interview. She believed that HIV was deliberated 
created by the government and that minority people were used as “guinea pigs.”  Below, 
she reveals the targets, and alludes to the conspirators. When asked by the interviewer 
about her thoughts on the origin of HIV, Keira responded:  
 
It’s made. I think it’s man-made, yes. Hey, it is what it is. It got out there, how’d it got out 
there? Who knows? All it is, is that we know it’s out here… Something just tells me it was 
a man-made virus. It got out there, but I think it—I mean, something tells me it is. I really 
can’t say why; I just have that feeling. Fine. They fucked up. They fucked up, something 
that went through the crack.... Even if, like I say, guinea pigs. They take the minority to 
test the virus. [Keira] 
 
Luis, a 55-year old Latino male, was diagnosed in 1988. At the time of the interview, he 
was preparing to leave his nursing facility of two years to move into a Single Room 
Occupancy housing until HIV/AIDS Social Administration (HASA) could help him find 
an apartment. Luis had a long history of incarceration, and had spent a total of 23 years in 
prison. He strongly believed that HIV was deliberately created to target minority people. 
Below, he explained his beliefs about the relationship between the conspirator 





I honestly feel that HIV was created in a lab.  Viruses could be contained in a dish.  We 
know that.  Come on…  Like I said, I believe in science and medicine and all that, right? 
When the virus first came out, it started attacking only certain types of segments of the 
population, right?  Homosexuals, people that were [drug] users, right?  Minorities in a 
way, right?  Blacks, you know what I’m saying?  Due to those facts, I felt that it was 
manmade, and a lot of people to this day still feel that… I think scientists got together 
with the government and made this to attack a segment of the population…Let me tell you 
about—I think back in the ‘50s, was it, where they took a segment of Black men and they 
injected ‘em with syphilis, right?...They [the government] didn’t tell ‘em, right?  To find 
out later on what the effects of it, the same way.  If the government was able to do that, 
man, what else do you think they gonna do?... I guess [they do it] for control, the 
population.  Let’s be honest.  You know that the Spanish population is gonna be the 
majority, right?  In this country, right?  If it’s not already, right?  That’s one reason they 
want to control the population, right, of different races, especially Caucasian races, 
right?  Basically, how they say they were the ones that basically made America, which is 
not true.  We know that.  We know that.  This country was made by different people.  How 
was the trains put together?  The Asians, Chinese…They were treated like nothing, like a 
nobody, right? [Luis] 
 
Luis was one of the very few participants that specifically alluded to the Tuskegee study. 
Although several others raised the issues of experimentation, Luis’s explicit reference 
further reveals his deep suspicions of the government, particularly in regard to its 
historical treatment of minority people. 
 
Pablo, a 44 year old Latino man, was diagnosed in 2001 during a visit to a methadone 
clinic. Pablo was still on methadone at the time of the interview, and had reported using 
heroin two days prior. He had experienced multiple periods of incarceration, spanning 
three decades, and believed he and other inmates were deliberated experimented upon in 
prison via an influenza or pneumonia vaccine that appeared to cause an outbreak of 
extremely painful boils (“When you’re in jail, you’re like a laboratory rat…This is true. 
Everyone knows that. They want to treat you with different things to see what	the	




underlying the origin of HIV. Below, Pablo explained why he believed the government 
created HIV to target certain groups: 
I believe [the government created HIV] for the homo, and addict, and Black 
community…I believe to control the population and take out other people—homos and 
things like that. I believe that. Everybody got different opinions. Mine, I believe that 
happens. [Pablo] 
 
Rejection of origin-related beliefs: The dissenters 
Although many participants expressed origin-related beliefs, a subset of the 
sample did not. These dissenters, presented below, are ignored by the literature, as such 
beliefs are considered to be highly prevalent among racial and ethnic minority people. 
The following data emerged from interviews with participants who did not support such 
ideas and some who strongly rejected them. 
 
Dee, a 49 year old Black woman, was diagnosed in 1988. Dee was engaged in HIV care 
at the time of the interview, but was not consistently adherent to her HIV medications. 
She attributed this to having been severely traumatized by the death of her HIV-positive 
21 year old son five years earlier. He had experienced horrific side effects from AZT as a 
preteen, and decided to stop taking his medication. Although Dee acknowledged that the 
newer classes of ART were safer and more effective, she was terrified of side effects due 
to watching her son struggle with them and eventually pass away. She rejected any notion 
that HIV was deliberately created to target a particular group, although she had heard this 
idea in regard to Black and gay people: 
 
Well, listen, I’ve heard it was put here for the Black man and stuff like that, right? Then 
they came up with cancer, so then the White people got cancer, so that’s what they get for 
development AIDS, right, HIV? But I don’t believe that. I don’t believe that crap. I mean, 




that it was a gay disease. You know what I’m sayin’? But you got all the people [in] 
Africa who has it. [Dee] 
 
Sandra, a 43 year old Black woman, was undetectable, engaged in outpatient HIV care 
and was consistently taking ART at the time of the interview. Having lived with HIV for 
over 25 years, she had experienced periods of disengagement from care and attributed her 
most recent period of disengagement to a lapse in her health insurance coverage. Like 
Dee, she also felt strongly that HIV was not created with the intent of targeting minority 
people: 
 
I know that it’s not a man-made disease.  I feel it in my heart that it’s not.  One can’t be 
that cruel and just let somethin’ out that like for the whole—for it to be exposed to the 
whole world.  It’s not only young people gettin’ it.  I seen a coupla older people, and 
their husband’s cheatin’ on them, and now they got it.  I seen Black.  I’ve seen White.  
I’ve seen Hispanic.  I’ve seen Mexicans.  I seen all type a people gettin’ it, so it’s not just 
a Africa thing.  It’s a worldwide thing now.  It’s like it’s spreading, and it’s spreading so 
rapidly that before you knew it, it was here in the United States of America. [Sandra] 
 
Jada, a 29 year old Black woman who was born HIV positive, had been experiencing 
severe kidney problems around the time of the interview. At the time of the interview, 
she had been taking ART for three consecutive weeks, after multiple periods of 
adherence and non-adherence. She stated that she had never been able to stay 
undetectable long enough to be put on the kidney transplant list, although she planned to 
overcome her “psychological” barriers to taking pills in order to become consistently 
adherent and ultimately undetectable. When asked about her ideas about where HIV may 
have come from, Jada responded:  
 
Oh gosh.  I’d like to stay out of that conversation.  [Laughter] I really do…It just makes 
me laugh.  People and what they think and believe, it’s not what they think, or what they 
thought, or believe.  It’s what they’ve heard… the most preposterous stuff.  That’s what 





CeeCee, a 48 year old Black woman, was diagnosed in 2006. She was undetectable and 
reported having been on ART consistently for one year at the time of the interview. She 
reported having struggled with alcohol and cocaine use. This contributed to her difficulty 
staying consistently engaged in care, as she reported that she had sometimes sold her HIV 
medication to pay for cocaine. CeeCee similarly rejected origin-related ideas, stating “a 
virus is a virus”:  
 
I think if somethin’ comes out, it comes out for everybody.  Just maybe more Black people 
caught it or whatever, but I don’t think it was targeted for just Black people.  That’s a 
bunch of crap…I don’t care who you are.  If there’s a virus, it’s gonna hit whoever got it.  
It don’t have a color on it.  It don’t say hit the Black people first.  A virus is a virus.  It’s 
gonna hit—and the reason why it must’ve hit a lot of Blacks is because if it came from 
Africa.  Maybe they were more Black people, and more Black people are having sex at 
that time than the white people. [CeeCee] 
. 
Jimmy, a 39 year Black man, was diagnosed in 2012. Recently married to his longtime 
partner, Jimmy began taking ART after his latest discharge from the hospital three years ago. 
At that time and while hospitalized, he had expressed that it had been difficult for him to 
consistently take his HIV medication because each pill was a reminder of his diagnosis. After 
nearly years of remaining adherent to his ART, Jimmy explained how he now thinks of ART 
as a “blessing.” He also rejected genocidal ideas regarding the origin of HIV, and considered 
such ideas as being used to fuel “race problems” by “white supremacists.” When asked about 
the context in which he has heard about these ideas, Jimmy responded: 
 
… I have heard it used to fuel race problems…I have seen propaganda from some white 
supremacist groups that are like HIV and AIDS is from Africa.  It’s an African disease.  It is 
a black disease.  AIDS is a black disease.  It’s from Black people, for Black people.  Black 
people have spread this disease.  …I haven’t gone any further than that because I’m just like 
really?  I haven’t invested any energy into that... I think a lot of these white supremacist 
groups always find different reasons to figure out ways to bolster themselves to be better 




country right now.  It always has been, but it’s particularly hot at the moment.  I guess it’s 
never really stopped being hot. [Jimmy]  
 
Although many participants endorsed some variation of the idea that HIV was deliberated 
created to harm minority people, some also clearly dissented in regard to the endorsement of 
origin-related ideas. However, even those who did not embrace the belief that HIV was 
created to eliminate minority people, acknowledged racism and the powerlessness of racial 
minority groups and how these forms of social exclusion supported the ideas we tend to call 
“conspiracy beliefs.” 
 
Theme 2: Beliefs related to a cure for HIV  
Both those participants who endorsed the idea that HIV was manmade by government or 
scientists, and those who did not endorse this idea believed in variations of the notion that 
there was already a cure for HIV, but it was being withheld by the pharmaceutical industry 
and/or government.  This was the most commonly shared belief among the sample. There 
were many variations of cure-related beliefs, and the vast majority of participants endorsed at 
least one type of cure or pharmaceutical-related belief, and frequently, more than one.  
The following interconnected subthemes emerged: 1) a cure is in fact available but 
withheld from poor and minority people; 2) rich get better treatment, if not a cure, because 
they can pay for it; and 3) keeping people sick is good for big business. Some explicitly 
believed a cure already existed, and was being deliberately withheld, while others believed 
scientists were still working on a cure, but when it is finally developed, it will be withheld 
from poor minority people. Thus, these ideas revealed participants’ perceptions of minority 
individuals as targets of exploitation, and the pharmaceutical industry and/or government as 




reveals an additional dimension, or perhaps actor, in this scenario: wealthy people that were 
considered as being in sharp contrast to the “poor”, which most of the participants identified 
with on some level. In the absence of a cure, some participants expressed their suspicion that 
rich people living with HIV had access to superior medication.  This theme highlighted 
another socioeconomic facet: the perception of the conspirators as a vaguely defined, 
powerful entity engaging in “big business.” Underlying these beliefs was a pervasive sense of 
socioeconomic exclusion and powerlessness.  
 
The cure is being withheld   
Jamal, a 36 year old Black man, was diagnosed in 2010. At the time of the interview, he 
was disengaged from outpatient HIV care and not on ART. He stated that he “didn’t like 
taking pills”, and reported occasional methamphetamine use and a history of depression that 
he stated was also interfering with his ability to try to re-engage. Jamal was deeply suspicious 
of the government and the pharmaceutical industry. It is noteworthy that in the quote below, 
the participant, not the interviewer, introduced the phrase “conspiracy theorist”: 
 
I believe there’s a cure out there because Germany released something a couple years ago 
where—something with stem cells, and they got rid of the HIV in that one man.  We heard 
about that couple years ago.  We haven’t heard anything else.  Magic Johnson—he’s had it 
for fifty, sixty years now, and he’s healthy as a horse.  If I had millions of dollars, I’d be 
healthy as a horse too.  There has to be a cure.  There has to be if Magic Johnson is still 
alive, kicking.  You’d never know he had HIV.  Just sayin’, the guy in Germany—you can get 
rid of it… We haven’t heard about it because they don’t want us to hear anything else about 
it.  Our media is very skewed into one or two lanes.  Yeah, we only hear what they want us to 
hear.  Right now, that’s not what they want us to hear, so we won’t hear anything else about 
it… They can still control us.  Oh, I do sound like a conspiracy theorist.  We can still be 
controlled.  We’re still at their beck and call.   [Jamal] 
 
When asked her thoughts about the possibility of a cure already being available, Keira who 




that in fact a cure likely already existed, but was being withheld to maximize the profits of 
the pharmaceutical companies that are producing ART. She stated that she was disinclined to 
examine this issue, and was “not checking out” this idea because she was not a “scientist”, 
suggesting a sense of powerlessness as a consumer of HIV medication that has no choice but 
to adhere to the treatment if she wants to live: 
 
It may be, it may be out there, but I’m not the one—I’m not in no position to say there is, and 
I’m not checking it out because I’m not a scientist. None of that…Scientists, it’s all about 
them finding—okay, finding the cure for the virus. Then again, if scientists is making a pill, 
that pill is money. For them to keep making pills and making this, they need money. They 
probably will find it. They probably do have the cure, but they just don’t wanna take it out. 
Because if they get cured, that gamble right there has taken care of the virus, holding the 
virus, is not gonna be there if they find a cure, so there’s—the money is not gonna be there. 
Because how they get paid? How do they get to funding for this, to do the research? To keep 
looking, and all that? It’s through the pills that they give us. [Keira]  
 
Aliyah, the 28-year old woman introduced earlier, also expressed suspicion that a cure may 
already exist, but that it would not be available to “us” that is, to her or other low income 
Black people:  
 
Once [my mother] told me and me and her sat down and basically talked, cuz we talked 
about things that I’ve heard like, “Oh, I heard that there was a cure.  Hopefully we could get 
our hands on it.”  My mother basically just told me—my mother’s never kept anything like on 
the hush-hush with me.  Like she was always straightforward.  She basically told me that 
you’re gonna have this for the rest of your life and there might be a cure out there, but we’re 
not gonna benefit from that…We won’t be able to get it…They just haven’t found it yet or 
they just don’t want to give it to us. [Aliyah] 
 
 
If there is not a cure, then at least there is better medication than the one I am getting 
Some participants also believed that Magic Johnson, as evidenced by his apparent good 
health that they inferred by his healthy physical appearance and longevity, had access to 




woman, expressed confidence that a cure for HIV would one day be found. Diagnosed in 
1990, she was undetectable and adherent at the time of the interview after years of struggling 
with accepting her illness. Further, her sister had passed away from AIDS-related 
complications, and Sandra had witnessed her family stigmatize and mistreat her sister, and 
this led her to avoid disclosing her own status and amplified her denial.   Sandra questioned 
whether or not Magic Johnson was perhaps able to access superior HIV medication due to his 
wealth:  
Magic Johnson is doin’ damn good, and I wonder what he is takin’ cuz he can’t be takin’ the 
same medication I’m takin’. [laughs] Magic Johnson does not look like he has the virus at 
all.  When I say, “At all,” at all, he does not look like he has the virus.  They say people with 
money get certain treatments...I think he’s takin’ somethin’ super.  I don’t know what he’s 
takin’, but he doesn’t look like he—he didn’t lose any weight.  I don’t know.  I don’t know 
what it is.  He does not look—if I didn’t know that he had HIV—if I didn’t hear it on TV, I 
wouldn’ta known that he had HIV.  He just looks the same.  His skin complexion—
everything.  It looks the same.  I don’t know.  Maybe he caught it in time.  Who knows? 
[Sandra] 
 
Sandra did not specify who are “they”, that is, the people that disseminate the belief of the 
availability of superior medications for the wealthy. However, her statement that there are 
health advantages enjoyed only by the rich patients like Magic Johnson clearly reveals her 
belief that higher socioeconomic status provides access to what is otherwise unattainable for 
those who are not wealthy. While she did not endorse the idea that a cure already existed, she 
did believe that her lower socioeconomic status precluded her from superior medication 
available to the wealthy.  
 
Manuel, a 52 year old Latino man was diagnosed in 1996. He was engaged in care and 
adherent to his ART at the time of the interview, though he reported occasionally missing 




would reschedule missed appointments and felt overall that he was doing well. After two 
hospitalizations in the previous seven months for chest pain, he recently received two stents 
in his heart, and stated that he was “doing great now.”  Below, Manuel described finding out 
about pharmaceutical research being done in Puerto Rico that possibly suggested to him that 
a cure for HIV was being developed. Although he was uncertain about the idea that a cure 
already existed or would soon be available, he did suggest that “better treatment” is perhaps 
available to wealthy people, such as Magic Johnson, though he did not “know how this (with 
money your get better treatment) work[s]”: 
 
They say they got the cure for HIV…The other day I heard that they had the cure on the TV.  
I heard it.  Well, I don't know what they were talking about but they say—they were doing a 
lot of tests for a lot of people, even in Puerto Rico. Puerto Rico, they got a big, big—on 
Macao, they got a big pharmaceutical.  They be testing a lot of people like some kind of 
injection.  I don't know.  And they be test 'em and they be not finding the HIV in his blood.  I 
know, because I know—I do a little bit research with friends. Even look at this guy, Magic 
Johnson.  Magic Johnson have HIV.  And look at that man.  He's like this.  Why?  I don't 
know what kind of treatment he's getting.  Maybe because he got the money to get a better 
treatment, but I don't know how this work...[Manuel] 
 
Tanya, a 40 year old Black woman, was diagnosed in 1993. For the eight months prior to the 
interview, she had been sober and had not relapsed due to her participation in a drug 
treatment program for her crack use. Although she still “occasionally” missed a pill or an 
appointment, she reported that she took her medication regularly and that stopping her drug 
use made it possible for her to become engaged in care again. Tanya believed a cure likely 
existed and that Magic Johnson was able to access it due to his wealth, or at the very least has 
been able to pay for superior ART that is not accessible to low income people. Tanya did not 




most participants did; rather, it seemed that there was an amorphous “they” that deliberately 
withheld the cure from “poor people”: 
 
Yeah, there’s a cure, but they don’t wanna give it to us.  Us poor people, they don’t wanna 
give it to…They got it for the rich people.  They’re not givin’ it to us.  They gotta make us 
work for—by the time they have a cure for us poor people, we’ll be dead already..  Magic 
Johnson got a cure.  He paid for it, but it’s a cure out there..He got his cure done…Magic 
Johnson paid to get the higher meds… He said it on TV!...Do you watch Oprah?  When 
Oprah was on, remember when he came out and said he was HIV-positive the first time?  He 
found a cure for him.  He paid for it.  Now, he still HIV-positive, but it’s a better med for him, 
a more expensive one.  Same us Black people can’t afford… They’re keepin’ it away from the 
people that need it…The poor people!  If you don’t have the money—the efficient funds to get 
it, you’re not getting’ it. [Tanya] 
 
 
Exploitation by Big Business  
The subtheme of big business was closely related to the belief that the pharmaceutical 
industry and the government, as conspirators, were in collusion and were deliberately 
withholding the cure for HIV. For Aliyah, who is quoted below, “big business” referred to 
the pharmaceutical industry and signified to her that greed related to the profitability of ART 
determined the industry’s activities and therefore, would likely prevent the release of a cure. 
In this sense, she perceived the government/ pharmaceutical companies as selling effective, 
necessary medication that enables someone with HIV to survive so as to remain an active 
consumer. Her quote below, alludes to the government and pharmaceutical industry’s 
exploitative practices:  
 
HIV’s a big business, you know what I mean?... Just like the government, the pharmaceutical 
people.  It’s business.  Any time any type of disease come up, somebody’s gonna make that 
vaccine so they can make money off of it.  …  The fact that it costs—it wouldn’t do the 
government any good to cure us.  It’s better to keep us infected because why they—even if the 
pill was a million dollars, you know what I mean?  All you’ll get is a million dollars for one 




person.  We have to keep taking this medicine.  We have to stay alive.  It’s just big business. 
[Aliyah] 
 
Jamal also expressed a deep suspicion of the relationship between the pharmaceutical 
industry and the government, including Medicaid: 
 
I betcha the pharmaceutical companies have a lot to do with it because HIV medication is so 
expensive.  Yeah, I betcha they’re in cahoots with Medicaid ‘cuz—I bet, dollars to donuts, at 
least 67 percent of HIV cases in the city, everybody’s in Medicaid.  They’re getting’ some 
type of kickback.  They would lose money, or pharmaceutical companies would fold if they 
just said, “Oh, ta da, there’s a cure.  Aha.”  Yes, just go in and give ‘em a stem cell of a 
baby, and you’d be all set.  Yeah.  There’s some palm-greasing going around, like, “Keep 
this cure for a couple years while we stack our coffers or while we come up with some other 
something to accidentally release onto someone.”  I’m sure, one day, there’ll be a cure, but 
probably not any time soon, just because the [government] wanna keep us paying 
pharmaceutical companies. …It’s a cycle.  It’s cyclical.  This person pays this person… but I 
think once they realized that we’re gonna pay all this money, and all these non-profits are 
gonna raise these money—you go down here, and they march for AIDS, and they make 
millions of dollars, and then they put it back into the pharmaceutical companies so they can 
give these people these pills.  [Jamal] 
 
For Luis, “medicine”- encompassing pharmaceutical companies, pharmacies and hospitals- 
was “big business.” Notably, however, he did not include individual providers in this band of 
co-conspirators:  
 
Economics.  You know how much HIV medication costs?  Billions of dollars, right?  Just to 
make it and research it, right, to get it, right, FDA-approved, right, and get it out there, 
right?  There’s some money to be made with these pills.  They don’t want people to get—to 
get cured, right, because then…Medicine is one of the biggest industries in—we know that.  
Not in the country, but in the world.  I mean, just walk down this block here…Pharmacies 
and hospitals…HIV is big business.  Big money. The pills, everything.  The treatment, 
everything is big money. [Luis]  
 
Below, Pablo included doctors and pharmacies in the profit-oriented “family” that comprised 
pharmaceutical companies, the government, pharmacies, and doctors. Pablo’s inclusion of 
doctors in his understanding of the government-pharmaceutical scheme was unique and not 




belief that HIV was created with genocidal intent. He stated that he and other men were 
experimented on by health care providers while in prison, which may account for his 
inclusion of doctors in this exploitative “family.” Below, he described why he believed a cure 
already exists for HIV: 
 
They got it. I believe in my heart and everything that they got the cure, but the money is more 
important for [the government]. I believe that…because right now, they got a company with 
the medication…You know how many billion and billion and billion a year they bring 
through that medication?... I believe that it’s a big family—the company that make the 
medication, right? Going with the government, the company that made the medication, 
doctor, pharmacy, they come together. They like one family. They business. They’re terrible, 
these businesses. Nobody can tell me no business, you can see that. You can be blind to not 
see that it’s business. [Pablo] 
 
The previous two themes, origin beliefs and cure beliefs, revealed the texture and variety of 
these ideas, as well as the conspirators and targets in these scenarios. Many participants 
endorsed the idea that a cure exists but is being deliberately withheld by the pharmaceutical 
industry and/or the government. Participants perceived poor people, particularly those of 
color, as being excluded from any potential benefits of an existing or soon-to-exist cure, in 
contrast to wealthy people that have the means to access the cure, or at least superior ART 
that ensures longer survival and better overall health. Moreover, the widespread perception of 
the conspirators as a vast, powerful entity that targets poor, primarily minority people, was 
evident in participants’ characterization of these conspirators as “big business”, which 
comprised primarily the government and pharmaceutical industry, and also, although less 
often, pharmacies, hospitals and doctors as well.  
 
Theme 3: The overlooked dismissive disposition or reaction to “conspiracy beliefs” 
A third theme that emerged from the data was an expression of avoidance and 




participants’ dismissive and/or avoidant disposition suggested uncertainty about whether 
these ideas were true or not, or indifference, while others appeared to prefer not to even wish 
to contend with these ideas. Some of these participants’ narratives revealed that they 
preferred to avoid discussing, thinking about or expending energy on the possible origins of 
HIV, or the possibility that a cure already existed but was being withheld. This avoidant 
stance was associated with discussions of the issues participants did in fact want to focus on, 
namely managing their HIV, their overall health, and dealing with other pressing challenges 
in their lives. It appeared that for some participants, even the mentioning of the ideas that the 
literature calls “conspiracy beliefs” led them to “block [it] out”, or to explain why they were 
irrelevant to the management of their daily lives. In this sense, thinking about or dwelling on 
the possible origins, or the idea that they may be missing out on a cure, was perceived as 
unproductive, or even perhaps psychologically destabilizing and/or distressing. Thus, in 
expressing that thinking about, or even discussing, such ideas was in their opinion a waste of 
time, participants revealed what did in fact matter to them- taking care of their health, and by 
extension, prevent others from getting infected. In this sense, these kinds of beliefs “didn’t 
matter” because HIV is an irreversible disease that can be a chronic condition if taken care of 
properly.  
For Jay, quoted below, these kinds of ideas constituted “negative stuff”, which he tried to 
“block out.. Jay, a 31 year old Black man diagnosed in 2009, was disengaged from outpatient 
HIV care and not on ART at the time of the interview. He was interviewed at his bedside 
while hospitalized for fatigue, shortness of breath, and, in his words, “probably a little 
pneumonia.” At the time of the interview, Jay had been hospitalized for similar reasons twice 




presented here, Jay stated that he “hated talking about” his status, remarking, “I just can’t be 
cool with it.” He appeared disinterested or perhaps even avoidant when asked about ideas 
related to the origin or treatment of HIV: 
 
…when I hear [these ideas], I just block everything out.  I don't hear nothing you're talking 
about.  I stay to myself and I'm gonna always be to myself… That's about it.  I don't speak to 
people really.  You can talk, I'm not listening to you.  I mind my business… I don't pay 
attention to the negative stuff. [Jay] 
 
When asked about the possibility that such ideas may be true, Jay responded that he did 
believe experimentation occurs, but could not invest time and energy thinking about it: 
 
I mean, I do, but I don't. I think they experiment with a lot of stuff and things happen, and the 
stuff just starts forming.  I can't be thinking about all that.  I got other stuff to think about…  
[Jay]  
 
For Jay, “stay[ing]” to himself, and not engaging in distracting conversations about 
“conspiracy beliefs”, was one way that he was able to “mind [his own] business” and not 
“pay attention to the negative stuff.”  Jay did not believe in any particular “conspiracy 
beliefs”, and seemed to be purposefully dismissive or even avoidant of them.  
 
Tina, a 53 year old Black woman, was diagnosed in 1995. She was engaged and undetectable 
at the time of the interview, after many years struggling with forgetting to take her ART, and 
missing appointments due to “runnin’ the streets” and “being in denial.” In her words, “I 
don’t know why.  I had it so long, but I was just in denial, but I take ‘em [ART] now.” 
Below, she explained how she focused on taking her medication rather than pondering the 





I hear, but I don’t listen to everything I hear.  ‘Cause if it was really out there, I think 
somebody would’ve brought it out, said somethin’, and put it out in the like—I don’t know.  I 
don’t know. I don’t even think about that.  I just take my pills. [Tina] 
 
Tina had heard such ideas being discussed, but was not interested in participating in such 
discussions, or investing time and energy in pondering whether such ideas were true or not. 
She vaguely hoped that if a cure did exist, it would become known, but even that hope was 
not one that she thought deeply about.  Her statement, “I don’t even think about that.  I just 
take my pills”, reveals how her thoughts and ideas about the possibility of a cure did not 
impact her daily life, nor her desire and ability to consistently remain on her ART. 
 
Maria, a 34 year Latina woman, was diagnosed in her early twenties. She was undetectable 
for the first time in her life, and living in a nursing home at the time of the interview. She 
attributed her previous disengagement to her alcohol abuse, but at the time of the interview 
had been sober for approximately a year and a half, and this enabled her to manage her 
multiple health issues, including HIV and recently being diagnosed with narcolepsy. Below, 
Maria emphasized the importance of managing and preventing HIV over thinking about the 
possible origin of HIV, and described these types of ideas as “stereotypical”: 
 
I never inquired more about it, because I really don’t care.  [Laughter]  I just care about 
being healthy and living…Honestly, if you ask me, I really don’t care where it come from.  I 
have it and I need to get rid of it.  You know what I’m saying?  [Laughter]  It’s not my 
judgment of who made it or who passed it around or just those stereotypical things.  I really 
don’t care.  The only thing I care about is to help stop it, to help reduce it, and to help people 
just take care of it... It really doesn’t matter where it was made at. What matters is that, what 
are you gonna do about it? [Maria]  
 
Myra, a 44 year old Black woman, was diagnosed in 2006 and had never engaged in care 
until approximately two years prior to the interview, when she became stably housed after a 




patient”, and was doing very well taking care of her health. Myra was not particularly 
interested in thinking about or discussing any origin or cure-related beliefs, as she was 
focused on managing her health: 
 
It really doesn’t matter to me actually…I wouldn’t know.  It doesn’t make a difference.  Once 
you have it you have to treat it.  If you don’t, you just basically die and you could affect 
others and others that don’t know that they have it.  You’re forcing them to not treat theirself.  
[Myra] 
 
Janae, a 42 year old Black woman, was diagnosed in 2003. She had been consistently taking 
ART for approximately a month at the time of the interview, as she had recently started a 
new regimen after a period of going off ART due to severe side effects. When asked if she 
was familiar with ideas about the human-made origin of HIV or the idea that a cure exists, 
she responded: 
 
That’s hearsay.  I don’t pay attention to it.  I just turn the TV, ‘cause you ain’t gonna get my 
hopes up high… you just gotta keep yourself healthy and keep yourself protected. [on cure 
rumor]… …you gotta do the best thing to do to make you live for yourself, and stop listenin’ 
to these peoples.  Make sure—you gotta take care of your body.’…I don’t worry about 
people.  I worry about myself.  I can’t worry about what this person have or worried about 
lookin’ up researches.  I don’t do that.  I got other issues.  I got other problems. [Janae, 229, 
AA female 42] 
 
Juan, a 49 year old Latino man, was diagnosed in 1984. He had moved back to NYC 
approximately a week before the interview, after living in a rural part of a southern state for 
eight years. During those eight years, Juan had not received any type of medical care for his 
HIV. He had been hospitalized for a week prior to the interview due to an HIV-related 
stomach infection, as soon as he arrived to NYC. He stated that he chose to move back to 
New York in order to begin receiving care and taking ART, and had an HIV care 




frustrated with the topic, which perhaps suggested that such ideas could be destabilizing to 
his already precarious situation: 
 
I don’t know where [HIV] came from.  I just know I got it.  Nothing—where am I gonna find 
out who?  It’s not gonna help me any.  It’s just gonna stress my mind out.  I don’t need that… 
Why would you wanna know where how it came from?  Could it cure you?  Can it get you—
can it give you the life—the day and the hours and minutes and seconds that pass by them 
years ago?  Can it get you better?  Can’t do nothing for you, man.  Whoever invented it or 
how the hell it came about doesn’t concern me, as long as I stay alive. [Juan] 
 
Jamal expressed a deeper level of suspicion than most of the other participants previously 
quoted, but similarly conveyed his belief that what was most important was taking care of his 
HIV by taking his ART. In discussing his perceptions of the pharmaceutical industry, he 
suggested that he understood the profit-driven cycle, but believed ART was an effective 
treatment for HIV:   
 
As long as I’m getting the pills that I need, I think I’ll be fine…I’m supposed to go and get 
the pills, and Medicaid gets their voucher, and then they send—yeah.  I would fulfill my role 
in the cycle.  Everybody needs to get paid would get paid, except for me. [My role is] to go 
and get the pills and take them.  Actually, my role could just be to go get the pills.  I don’t 
have to take them.  As long as I go get them, I can go and throw ‘em all in the river, and at 
that point they wouldn’t care because I got my pills.  I went to the pharmacy.  CVS got paid.  
Callen-Lorde got paid.  Abbott got paid…I don’t feel like they’re placebo pills or things like 
that.  I don’t think that, when I go in and get my T cell count, that they’re just makin’ these 
numbers up, and the more they don’t see me, the worse the numbers get.  I don’t think that.  I 
do think that there’s value and benefits to taking your meds. [Jamal]  
 
Discussion 
The data revealed two main findings: 1) the variation and texture related to people’s 
beliefs about HIV, including ideas related to the origin of HIV, its treatment, the possibility 
of a cure, and the role of the government and pharmaceutical industry in the epidemic; and 2) 
endorsing these kinds of beliefs does not necessarily directly impact engagement in care or 




highlighted the intersectional nature of social exclusion, particularly the racism and 
classism facing low income PLWH who belong to racial and ethnic minority 
groups. Notably, HIV care providers did not appear to be perceived as part of the 
government-pharmaceutical power complex, suggesting that while many people may endorse 
these types of ideas, endorsement does not necessarily directly impact engagement in HIV 
care.    
Participants’ accounts, that is, their articulations of their beliefs in their own words, 
highlighted dimensions that can inform our understanding of so-called HIV-related 
“conspiracy beliefs.”  First, illuminating variation and texture of various beliefs; second, 
revealing a strong socioeconomic component, which intersects with the racial inequality 
experienced by participants; and third, the ideas about the nature of the targets and 
conspirators discussed by participants that pertained to their perceptions of the government 
and the pharmaceutical industry.  
In the above quotes, participants’ experiences and understandings of powerlessness were 
revealed as having both targets and conspirators. Coming from people largely living on the 
margins of society- that is to say, socially and economically excluded- these narratives 
identified an incredibly powerful government-pharmaceutical complex that colludes and 
schemes to target “poor minorities.”  In many cases, the terms “the pharmaceutical industry” 
and “the government” were used interchangeably by participants suggesting a broad, 
structural mistrust of medication-producing corporations, backed by, or intimately connected 
to, the government. Sometimes the word “scientists” was used to refer to researchers that 




participants were often aware that many kinds of researchers and scientists receive 
government funding.  
Many participants endorsed origin-related beliefs and believed strongly that the 
government was responsible for deliberately creating and releasing HIV to specifically target 
low income racial and ethnic minority people, and possibly substance users and gay men. 
However, it is also important to document the perspectives of those who do not endorse such 
ideas. Even when participants disagreed with, or dissented from these ideas, there was a 
widespread recognition that racial inequality contributed to the prevalence of these beliefs. 
Previous literature has focused almost exclusively on the ways in which these kinds of ideas 
are associated with minority groups [17,18], but this study appears to be the first to explore 
the diversity and texture of viewpoints from the same socio-demographic population.  
Pharmaceutical, or cure-related, beliefs were the most common so-called “conspiracy 
beliefs” shared by participants. The expression of these ideas largely converged on the 
thought that the medication treatment for HIV is “big business” that makes “billions of 
dollars” for the pharmaceutical industry and the government. For example, many participants 
also cited the enduring good health of Magic Johnson as evidence that a cure was indeed 
already available, but only accessible by the wealthy. This belief was reinforced for many by 
the knowledge that HIV medications are extremely expensive, and this awareness, in turn, 
reinforced their understanding that the selling of HIV medications is vastly lucrative for 
pharmaceutical companies. The perceived profit margin was further reason to conclude that 
releasing a cure for HIV would go directly against the interests of the pharmaceutical 
industry and the government. This conflation points to how participants perceived 




Moreover, it is important to note that participants’ knowledge of research funding politics, as 
noted above, as well as their knowledge of the extremely high cost of ART, are centered 
around widely-accepted facts about the pharmaceutical industry. In particular, it is well 
known that HIV treatment is extremely expensive, and cost-prohibitive for millions of people 
around the world [24]. Thus, so-called “conspiracy beliefs” seem less paranoid when 
examined in the context of research and development politics, capitalism, a pervasive lack of 
access to expensive treatment globally, and the intertwined forces of racism and classism.  
Although most participants expressed deep suspicion of the government and the 
pharmaceutical companies, the data did not suggest that participants generally felt that 
individual health care providers are similarly powerful. This possibly suggests that 
participants did not perceive their providers to be motivated by greed or to benefit financially 
from prescribing ART. Although some participants mentioned pharmacies and, even less 
frequently, hospitals as part of the government-pharmaceutical power complex, these 
inclusions signaled that these entities were perceived as directly benefiting from the sale of 
ART. HIV care providers did not appear to be perceived as or considered co-conspirators 
with the government and pharmaceutical industry, although it was unclear whether or not 
participants believed that HIV providers were aware of the government-pharmaceutical 
collusion. Although some previous research has found that minority populations may be 
distrustful of health care systems [19,20], these findings are suggesting that people can 
harbor mistrust, even extreme suspicion, toward health and medical structures, but are able 
and desire to foster collaborative relationships with their respective HIV providers.  
  It is important to note that all participants in the study believed that ART allows people to 




pharmaceutical industry and government did not detract from people’s acknowledgement and 
belief that the medications produced by the industry are indeed life-saving (even if they 
believed that drug companies are not motivated by compassion and are in fact motivated by 
profits). Rather, the very fact that ART is so incredibly effective in prolonging people’s lives 
and improving the quality of their lives, and that this treatment success in turn also extends 
the consumption of ARTs was one reason why participants believed that a cure was being 
withheld. Treatment success, in other words, produced and reproduced a robust market of 
consumers. In this sense, the efficacy of ART was itself evidence that: first, pharmaceutical 
research has advanced enough to have produced a cure by now, and second, the accepted 
efficacy of ART and vast improvement over drugs available in the AZT era has enabled 
pharmaceutical companies to sell extremely expensive medications that are required to treat 
what can be a long-term, chronic illness -- an unintended consequence of the treatment 
advances in HIV.  
Although most participants endorsed some variety of origin or pharmaceutical-related 
belief (most commonly the latter), some expressed uncertainty or dismissiveness toward 
origin- and pharmaceutical-related beliefs due to a concern that delving into such ideas could 
derail participants from managing their HIV and their health. Expending time and emotional 
energy pondering “conspiracy belief”-type ideas was perceived as unproductive and even 
detrimental to efforts to focus on their health and other life challenges. In this sense, 
participants viewed time and energy as finite resources. Thus, some participants considered 
thinking about “conspiracy belief”-type ideas and managing their HIV, general health, and 
life challenges as an “either or” situation. This is a departure from the majority of public 




engagement and adherence [21,22]. These findings provide an opportunity to reframe how 
we conceptualize the role of origin and pharmaceutical/cure-related ideas in the lives of 
socially and economically marginalized people.  
Limitations and challenges 
This study utilized a purposive sampling technique to enroll 27 participants who were living 
with HIV, and had been recently, or were currently, disengaged from outpatient HIV care at 
the time of the interview. Although the sample size was modest, the interviewer achieved 
thematic saturation with the completion of 27 in-depth interviews. Moreover, the sample was 
diverse in terms of engagement status, that is, included participants that were at various 
stages in their re-engagement process, thus suggesting that this sample reflected the 
experiences of the larger population of low income people of color contending with 
challenges related to engagement in HIV care and consistent ART adherence.  
 Another challenge that emerged in this study was the different operationalizations of 
engagement and adherence in regard to the quantitative data and the qualitative data. The 
IAQ’s response choices for the items that were used to evaluate engagement were limited to 
fixed categories that appeared to have inadvertently resulted in a social desirability bias 
during the survey portion of the interview. The combination of the desirability bias and the 
instrument design-related limitations related to recall over six-12 months appeared to have 
resulted in a higher percentage of participants reporting they regularly attend clinic and 
consistently take their ART than was actually the case, as discerned during the qualitative 
portions of the interview. Thus, some participants’ quantitative data did not cleanly match the 
information they shared during the semi-structured portion of the interview. However, it is 




which a greater sense of trust and rapport was built over the course of the qualitative portion 
of the interview. Moreover, qualitative probing allowed for participants to provide nuanced 
responses to questions regarding their disengagement and re-engagement experiences.  
Finally, although the topic of “conspiracy beliefs” is often regarded as a social 
taboo or controversial, thus possibly increasing the likelihood of desirability bias, the 
interviewer took special effort to avoid making pre-judgments about participants’ beliefs. In 
order to provide an open, non-judgmental environment, the interviewer-administered 
questionnaire did not inquire about these kinds of beliefs, which allowed the topic to emerge 
as organically and neutrally as possible during the course of the conversational portion of the 
interview. Participants tended to raise the topic themselves, but in absence of that, the 
interviewer used neutral language to ask about beliefs regarding the efficacy of ART, the 
possibility of a cure, the role of the government, if any, in the epidemic, and the nature of the 
possible origin of the virus. These strategies, in addition to the extensive training the 
interviewer received on how to elicit sensitive information, helped reduce the chance of 
social desirability bias, and encouraged participants to speak candidly and openly about their 
belief system and their experiences with HIV care.  
	
Recommendations for further research and practice 
This data provides an opportunity to reframe how we think about “conspiracy beliefs.” 
Here, Garfinkel’s concept of “cultural dopes”-- society members that mindlessly reproduce 
social norms -- is useful for drawing attention to a more nuanced understanding of the 
meaning of origin and pharmaceutical-related beliefs among low income people of color 




of people who are often made powerless by intersecting structures of racial and 
socioeconomic inequality. Rather than being cultural dopes- specifically minority cultural 
dopes that endorse stereotypical, paranoid ideas associated with racial and ethnic minority 
groups- participants were largely reflective, critical and thoughtful about their own lived 
experiences. Thus, these findings present an opportunity to reframe the notion of “conspiracy 
beliefs” and more precisely contextualize them as not only reflections of the consequences of 
deeply rooted patterns of social exclusion based on race and class, but also of diminished 
expectations of health care quality based on past and ongoing experiences of structural and 
interpersonal racism and discrimination [24].  
Although widely used in the public health literature, the term “conspiracy beliefs” is 
problematic and does little to enhance our understanding of why people endorse such ideas, 
or the role that they may play in people’s everyday lives. Replacing the phrase “conspiracy 
beliefs” with more precise terms that describe people’s beliefs in a less judgmental and 
discrediting way -such as origin of illness-related beliefs and pharmaceutical or cure-related 
beliefs- has the potential to create more space to be critical in our efforts to understand this 
phenomenon, and thus design more effective interventions to improve engagement, 
adherence and retention. 
Importantly, the data suggest that people can endorse these types of beliefs, and 
successfully engage or re-engage in care and become adherent to ART. Previous studies on 
the relationship between HIV-related “conspiracy beliefs” and engagement and adherence 
have produced mixed results, but most suggest that holding such beliefs negatively impacts 
care [25].  However, most of these studies were quantitative in nature and examined the 




exploration of such ideas among a sample of participants that were largely inconsistently 
engaged and adherent at the time of their interviews. While some of them had successfully 
become re-engaged and consistently adherent after periods of disengagement, most of the 
participants were still attempting to become more consistently engaged and/or adherent. 
Notably, all participants in the sample had been disengaged from outpatient HIV care within 
at least one to three years prior to their interviews. Thus, this study was able to explore these 
beliefs among a group of people that were either currently struggling with consistent 
engagement and ART adherence, or had recently managed to re-engage or re-start ART.  
Moreover, these findings suggest that public health does not need to endeavor to 
dislodge origin- or pharmaceutical/cure-related beliefs; in fact, the data suggests that it may 
not be possible to change these beliefs, as they are inextricably linked to people’s experience 
of racism and classism. Interventions should instead focus on building trust between health 
care providers and populations that have been experienced both historically and ongoing 
socially and economic marginalization. It is meaningful and encouraging that HIV care 
providers did not appear to be perceived as part of the government-pharmaceutical power 
complex; although the beliefs explored here provide perspectives on social and economic 
exclusion and powerlessness, the data suggests that endorsing such ideas are not necessarily 
incompatible with engaging in care, re-establishing care, or the genuine desire to take one’s 
ART consistently. In an era of public health messaging that encourages the use of PrEP for 
higher risk groups, and ART for all people living with HIV, it is imperative to understand the 
meaning and significance of HIV-related beliefs among communities that are socially and 
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               Managing ART-related obstacles and the desire for therapeutic alliance 
with providers (experiences re-establishing care and/or re-starting ART) 
 
Abstract 
Background: Despite advances in HIV medication, many PLWH do not link to care upon 
diagnosis, do not remain engaged if linked, and do not achieve viral suppression through 
consistent ART adherence. Not achieving viral suppression is associated with low CD4-
cell counts, preventable hospitalizations, frequent emergency room usage, risk of 
developing a drug resistance, and excess morbidity and mortality. Despite extensive 
literature that explores barriers to care, these disparities remain, particularly among racial, 
ethnic and sexual minority groups.  
Methods: Over the course of one year, 27 semi-structured, in-depth interviews were 
conducted with low income PLWH of color living in the NYC area that are currently, or 
were recently, disengaged from outpatient HIV medical care. Additionally, a brief 
questionnaire was administered to obtain demographic and engagement/medication 
adherence data to describe the sample of participants.  
Findings: Facing challenges related to taking ART consistently, and strategizing to 
overcome them, were facilitating factors for participants that had successfully re-
established care, or were trying to re-engage in care. Endorsing positive beliefs about the 
efficacy of ART, and the belief that HIV can be a chronic disease if treated consistently 
also helped participants remain adherent or desire to re-commit to taking it consistently. 
Finally, the data revealed that participants appreciated, and desired, providers that 
engaged in patient-centered medicine. Having HIV providers that made them feel 
genuinely heard and cared for, particularly in regard to decision-making about ART 
issues, contributed to participants feeling agentic and more likely to remain in care and 
adherent.  
Recommendations: Participants’ emphasis on wanting to manage their ART-related 
challenges with their providers suggests that HIV providers have an instrumental role in 
not only lowering viral loads and achieving viral suppression, but also helping their 
patients feel agentic and able to manage their HIV. Implementing patient-centered 
medicine will also engender trust, thereby helping patients internalize the belief that 











Background and significance  	
HIV is now considered a chronic and manageable illness as a result of the advent 
of highly effective antiretroviral medication [1,2]. Consistent ART adherence is a critical 
part of the HIV care continuum (also called the HIV treatment cascade), which comprises 
the stages from first being diagnosed with HIV, becoming linked to care, and then 
remaining engaged and adherent, ideally culminating in viral suppression [3,4]. However, 
US-based studies have found that of those diagnosed with HIV, nearly a quarter (23%) do 
not link to care, and of those linked to care, 49% are not successfully retained in care [5]. 
Only 28% of people living with HIV (PLWH) are virally suppressed [6].  According to 
the CDC, “The largest lost opportunity to achieve a suppressed viral load in the U.S. 
occurs among individuals who have failed linkage to or retention in HIV medical care.” 
[7] Many PLWH, and especially those who belong to racial, ethnic and sexual minority 
groups, are not receiving ongoing HIV medical care [8-10]. Patients who are disengaged 
from outpatient care tend to initiate antiretroviral therapy later than clinically 
recommended. They also often have poor adherence to treatment regimens, which 
typically results in a number of problematic outcomes, including high viral loads, low 
CD4-cell counts, preventable hospitalizations, frequent ER usage, excess morbidity and 
mortality, and an increased likelihood of developing a drug resistance [11-13]. Moreover, 
poorly controlled HIV contributes to the transmission of the virus to sexual and drug 
using partners [11-13].  	
A wide range of barriers to HIV care has been well-explored in the literature. 
These include, but are not limited to, housing instability, mental health issues, substance 




However, much of the research on engagement and adherence, particularly barriers to 
care, has been quantitative in nature [17,18], though some recent studies approached this 
issue qualitatively [19].  Given how critical ART adherence is to achieving viral 
suppression, it is important to qualitatively explore how people think about engaging in 
care and adhering to ART, and to allow them to use their own words to describe how they 
feel about taking antiretroviral medication and the relationships they have with their 
providers. A qualitative perspective can add to our understanding of these complex 
phenomena and help contextualize some of the previous findings and make rhetorical 
space for patients to articulate, in their own words, their struggles with engagement in 
outpatient HIV care and ART adherence. Thus, additional research is still necessary to 
explore other possible mechanisms that may contribute to disengagement, as well as the 
factors that help facilitate re-establishing care.	
	
Methods 
Sample study population 
Participants for the study presented here were recruited from a larger sample 
utilized in a previous NIH-funded study (entitled Bedside to Community, and abbreviated 
as “B2C”). B2C examined disengagement from outpatient HIV care among hospitalized 
patients with HIV. To be eligible for the B2C study participants had to: 1) be age 21 or 
older; 2) self-identify as non-Hispanic Black or Hispanic (of any race); 3) self-identify as 
HIV-positive; 4) be confirmed as HIV-positive based on medical records; 5) report 
having been diagnosed with HIV for at least two years; 6) be currently hospitalized in the 




medical record; and 8) report that they have not seen any HIV outpatient clinician for at 
least 6 months (please see the appendix for a more detailed description of B2C eligibility 
criteria, including a revised operationalization of disengagement -criterion 8). 
 
Recruitment  
From July 2015 to May 2016, in-depth interviews with a purposive sample of 
twenty-seven (N=27) PLWH who, at the time of the interview, were currently disengaged 
from outpatient HIV care, or had been recently disengaged within the previous one to 
three years.  At the end of their B2C interview, individuals were asked for permission to 
contact them in the future to possibly participate in the study presented here, and if in 
agreement, asked to provide two to three different contacts (self, family, friend, etc.) to 
facilitate contacting them at a later date.  
The majority of potential participants were contacted via telephone using contact 
information they provided in the Permission to Contact form during their participation in 
the B2C study. Five participants were contacted in person when they were hospitalized at 
Presbyterian Hospital. Of the total 33 individuals successfully contacted (either via 
telephone or in person at bedside when hospitalized), 27 agreed to participate in the study 
presented in this paper. Two individuals declined participation, citing lack of time. One 
participant agreed to participate but was found to be not mentally competent and thus 
unable to provide consent, and the remaining three were reached via telephone, but then 
lost again when their numbers appeared to change or go out of service before an 





Data collection  
In-depth qualitative interviews can generate novel insights by enabling 
participants to express their life experiences and perspectives in their own words. 
Another advantage of semi-structured interviews is that they facilitate the emergence of 
topics that although unanticipated by the researcher, are salient in the participants’ 
narratives [20,21]. Given the potentially sensitive nature of the topic of one’s health and 
health-related beliefs, both these features of qualitative interviewing honor the 
participants’ ways of thinking and articulating their lived experiences. 
A semi-structured interview guide was developed to examine barriers and 
challenges related to engagement in outpatient HIV care and adherence to ART 
medication. Interview guide topics included questions about experiences with recent 
hospitalizations, housing circumstances, experiences with outpatient HIV care, ART 
adherence and experiences taking ART, other barriers to stable living conditions and/or 
engagement in care, and thoughts and beliefs about the nature of HIV/AIDS (please refer 
to the appendix for examples of interview guide questions). The qualitative interview 
portion ranged from 25 minutes to two hours, with an average of 45 minutes. The briefer 
interviews were due to participants becoming fatigued due to very poor health; hence, 
those individuals that were hospitalized at the time of the interview tended to have shorter 
interviews than those that were in better health and were able to come into the research 
center to be interviewed.   
Prior to the in-depth interview, an interviewer-administered questionnaire (IAQ) 
was also completed with participants. This five to eight minute survey gathered 




situation, public assistance status, recent hospitalizations, outpatient HIV care provider 
visits, and use of ART medication).  
In this study, engagement and ART adherence were assessed first in an 
interviewer-administered questionnaire (IAQ), and afterward discussed in-depth in semi-
structured interviews. The IAQ and the qualitative interview operationalized 
engagement/disengagement and adherence/non-adherence in distinct ways. The IAQ, 
which was completed first, assessed engagement and adherence with items that asked 
participants about any outpatient HIV care they had received in the prior six to 12 
months, including scheduled but missed appointments, as well as the spacing between 
each clinic visit. ART adherence was assessed with items asking participants if they were 
currently taking ART at the time of the interview, and if the ART was taken as directed. 
If participants indicated they were not currently on ART at the time of the interview, the 
IAQ assessed their intentions to begin taking ART in the next six months.  
After the IAQ, the semi-structured interview took place. The qualitative approach 
to categorizing participants by engagement status allowed for a descriptive, but less rigid, 
operationalization of engagement and adherence. Qualitatively, participants could be 
classified as consistently engaged, inconsistently engaged, or disengaged. The 
“consistently engaged” category indicated uninterrupted engagement over a period of at 
least the past 6 months, which necessitated both clinic attendance and ART adherence. 
“Inconsistently engaged” was a broad but descriptive category in which people may have 
only very recently re-established care (for a example, a few weeks prior to the interview), 
were taking their ART consistently but frequently missing HIV care appointments, or 




ART as directed. The category of “disengaged” indicated participants that were 
inconsistently attending clinic and not taking their ART on a regular basis or as directed.  
 
Data analysis 
All interviews were audio recorded for professional transcription. Twenty percent 
of the transcriptions were randomly selected for quality control and accuracy conducted 
by the first author (JJ). Analyzing qualitative data necessitates the development of a 
rigorous and organized method of managing and analyzing a complex set of data. This 
method must also ensure that the analysis plan does not compromise the conceptual 
richness of the data. The first author (JJ) implemented a multi-step method to 
systematically identify and contextualize the themes present in the data, which included 
developing a coding scheme and using it to discern patterns, themes and subcategories. 
The scheme was a hierarchically organized tool that ranged from the more general and 
abstract to more specific concepts. At the top of this hierarchy, the author (JJ) identified 
the analytic foci, which were coded as headings, then the core codes that refer to specific 
aspects or dimensions of the headings, and finally, sub-codes that refer to specific 
dimensions of the core codes. An example of a core code is “good patient-provider 
relationship,” as defined by participants, and examples of related to this code subcodes 
are “provider genuinely cares for patient” or “provider listens closely to patient.” After all 
of the transcripts were read multiple times and then coded, text segments organized by 
codes/subcodes were extracted in order to begin discerning higher levels of abstraction 
and to identify relationships among the various codes. The software Atlas.ti was used to 




were analyzed using SPSS and used to generate a description of the sample of 
participants.   
 
Results 
Quantitative findings  
Of the 27 participants, 59% were female (n=16), 41% male (n=11), 78% non-
Hispanic Black (n=21) and 22% Latino (n=6). Participant age ranged from 28-55. 
Seventy-four of the sample reported living in an apartment, SRO or room supported by 
public assistance and/or HASA (n=20). Twenty-six percent reported living specifically in 
an SRO (n=7) (of which are sometimes paid by HASA); 11% nursing home or hospice 
(n=3); one person reported being incarcerated at Rikers Island, and another was 
attempting to get their HASA re-instated after a paperwork mistake and was staying with 
a friend to whom they were paying rent. Thirty percent reported that they were homeless 
in the past 12 months (n=8).  
One hundred percent of the participants had Medicaid; two participants had both 
Medicaid and Medicare. Eighty-nine percent reported being unemployed at the time of 
the interview (n=24), one person was employed part-time, and two were employed full 
time. Specifically, 74% reported that they were unable to have a full time job due to not 
feeling well enough (n=20); 37% were not sure if they will stay well enough to maintain 
a job (n=10); 33% were fearful of losing medical benefits or other benefits if they worked 





 Seventy percent reported that they had gone for emergency care at a hospital 
emergency room (n=19) in prior six months to the interview. Among those that indicated 
they had gone to an emergency room (n=19), there was an average of 2.6 hospitalizations 
in the past six months; 95% of these participants reported that they were hospitalized 
overnight or longer.  
Using a 12-month interval, 78% of participants had visited a doctor or clinic for 
HIV care at least once (n=21), and 70% (n=19) reported having been to two or more 
scheduled medical visits at an HIV outpatient clinic and these visits were separated by at 
least three months. In the prior six months, 74% of participants had attended a scheduled 
visits and were examined by an HIV care provider (n=20); of these, 77% reported having 
missed at least one scheduled appointment (n=17). Finally, 81% (n=22) reported being 
currently on HIV medication at the time of the interview. 
 
Table 1   
Participants’ characteristics  N 
Gender Female 16 (59%) 
 Male 11 (41%) 
Race / Ethnicity Black Non-Hispanic 21 (78%) 
 Hispanic /Latino 6 (22%) 
Housing Situation* HASA or public assistance (apt or room) 18 (67%) 
 SRO 7 (26%) 
 No financial assistance Nursing home or hospice 
2 (7%) 
3 (11%) 














 Medicaid + Medicare 2 (7%) 
ER use past 6 months Yes 19 (70%) 
 No 8 (30%) 
Attended HIV care past 12 months Yes 21 (78%) 
 No 6 (22%) 




 No 7 (26%) 
Attended ≥ 2 HIV visits past 12 months Yes 19 (70%) 
 No 8 (30%) 
Currently taking ART Yes 22 (81%) 





Qualitative findings  
Theme 1: The art in taking antiretroviral treatment (ART)  
Participants were eager to discuss their various experiences and struggles with 
ART. The first subtheme, addressing obstacles related to taking ART consistently, was 
discussed by both those currently adhering to their ART regimen, as well as by those 
desiring to start or re-start ART in the near future. Although many contended with side 
effects, participants seemed especially interested in discussing challenges unrelated to 
side effects (e.g., pill fatigue, temptation to sell the ART, or being overwhelmed by the 
quantity of pills), and the strategies they devised to overcome or manage these 
challenges. Challenges often had both a physical and a mental aspect, which could mean 
that the obstacle was perhaps physical but required a psychological strategy; or that the 
obstacle itself was both physical and mental in nature, such as in the case of pill fatigue, 
where participants were physically and emotionally tired of taking daily HIV medication.  
The second subtheme, beliefs related to ART, revealed participants’ beliefs 
related to the notion that taking ART was necessary for long-term survival. Overall, 
participants had to think about and employ strategies to overcome various obstacles to 
their consistent life-long adherence, and positive ART beliefs facilitated their desire to 





Non-side effect related challenges to ART adherence and management strategies  
 Although fear of side effects, or experiencing distressing side effects posed serious 
potential and actual barriers to adherence or re-starting ART, participants also discussed 
other physical and mental challenges related to taking daily HIV medication, such as pill 
fatigue, problems swallowing the pills, and forgetfulness. For example, some struggled 
with what they often termed “pill fatigue,” and expressed the desire to take “pill 
holidays,” or other reported aversions to swallowing pills. Participants were both 
thoughtful and eager to reflect on their adherence challenges, and their devised strategies 
for overcoming them. Moreover, they were often very aware of their respective 
tendencies that led to non-adherence, such as past experiences with selling their ART, or 
the reasons underlying their aversion to swallowing pills, and discussed possible ways of 
addressing these tendencies that undermined their health and threatened their life.  
 Participants often used the phrase “pill fatigue” to describe being tired of taking 
HIV medication daily. This phrase indicated both being physically and mentally worn out 
from having to take ART daily. For example, Maria, a 34-year old Latina woman, was 
undetectable for the first time in her life, and was living in a nursing home at the time of 
the interview. She attributed her previous disengagement from medical care to her 
alcohol abuse. However, she had managed to become and stay sober since 2014, and this 
enabled her to manage her multiple health issues, including HIV and recently diagnosed 
narcolepsy. She also was part of an ART adherence program, which required her to send 
a text message when she took her medication. In the past, Maria had struggled with what 






Interviewer: Do you think you’ll have—what will happen if you start encountering pill 
fatigue again or you don’t want take your HIV meds?  How will you deal with that? 
 
Maria: Well, I have an alarm set on my phone, so it constantly goes off if I don’t.  I get 
annoyed…If I don’t type “okay” in a certain amount of time, it keeps going.  It’s with a 
program called [name]…It’s been working good.  Sometimes I take my medication, I 
forget to text “okay,” so I gotta go online and go to the website and let them know. 
[Maria] 
 
Luis, a 55-year old Latino male, was diagnosed in 1988. At the time of the interview, he 
was preparing to leave his nursing facility of two years to move into an SRO until HASA 
could help him find an apartment. He had recently re-started ART, and was determined to 
take them consistently and avoid taking what he called “pill holidays”, i.e., periods of 
time when he would not take his medication. He also revealed that the motivation for 
taking a pill holiday was to feel normal and in control of his life, whereas when on 
medication, he felt he relinquished control of his life to the pills:  
 
Interviewer: Since we saw you last, two years ago, have you had any of those feelings, 
that medication is just a negative reminder? [note: the participant had articulated that 
taking ART had been a constant “negative reminder” of his status in his first interview).  
Luis:: Sure, sure.  To say no, I would be lying.  Of course, I still get like that from time to 
time, that I say, damn.  I have to take these pills for the rest of my life, and it’s a constant 
reminder…We have a thing—people that have the virus have a thing called—they take a 
[pill] vacation… Off for a couple of [meds], and I think I’m just gonna enjoy life.  Just 
forget about everything.  Just put everything down and try to be as normal as I can… I do 
that now and then, yeah.  When I do it [take a pill holiday], I feel like I’m in more control 
of my life, man…I feel that I look at these pills and these things [are] controlling 
me…when I take the holiday and vacation, I feel in more control of my life.  I’m not sick.  
I don’t have HIV for today.  I don’t have no heart condition.  I don’t have nothing. [Luis] 
 
To help keep himself adherent, Luis also planned on asking his HIV provider for a pill 
tracker to assist him in remembering to take his ART: 
 
As far as taking my [meds]—I’m gonna do everything in my power to keep up.  I’m 
gonna get one of them—have a thing where they have—where it has days, and you got 




put everything in that, yeah.  Get me a watch with a timer, or on my phone. [Luis] 
 
Tanya, a 40-year old Black woman, was diagnosed in 1993. For the eight months prior to 
the interview, she had been sober and had not relapsed due to her participation in a drug 
treatment program for her crack use. She reported having struggled with taking her ART 
consistently due to her aversion to swallowing pills. She had tried to crush them or break 
them apart, but the taste was equally challenging. Over time, she had to train herself to 
swallow the pills whole, which helped her become adherent. This obstacle, which was 
physical in nature, required her to develop a psychological strategy to overcome it: 
 
… I just never liked to swallow pills, and I had to learn to take my meds if I wanna live.  I 
tried the crushin’ up thing, like I told you before.  I don’t like the way the pills taste…I 
had to learn how to swallow my pills.  One time, my husband had to break ‘em in half, 
and I take it like that.  I didn’t like that way, so I had to force myself to let it slide down.  I 




At the time of the interview, Jada, a 28 year old Black woman who was born with HIV, 
was inconsistently taking her ART, but desired to become undetectable in order to 
become eligible for a kidney transplant.  Her difficulties becoming consistently adherent 
were exacerbated by her extreme aversion to pill-taking, which she described as a 
psychosomatic reaction stemming from a lifelong need for various medications to 
manage her multiple chronic conditions, that is, primarily HIV, but also diabetes and a 
kidney-related illness.  
 
… I have to find the space where I understand that it’s mind over matter…It doesn’t 
matter what med it is.  It really doesn’t.  It can be HIV meds.  It can be diabetic meds. I 
think any meds will make me nauseous…Just the thought alone still makes me ill a little 
bit, uneasy in my belly. I don’t know how it got programmed in there like that.  I don’t 




mind…I’m workin’ on it...I’m trying ways of taking meds and then not having to really be 
coherent after...  I’m noticing that it’s better.  It’s getting better this way—…It’s like, 
maybe, [taking it at the] end of the day stuff or early morning, morning. Then it’s just like 
when you go in the day, everything else starts to occupy your mind so you’re not thinkin’ 
about it.  When you go to bed, you take ‘em…Then you’re dreaming all night.  Even if it 
is bothering your tummy, you never leave [the house].  That’s how I’m working with it. 
Otherwise, if I try to take it, 2:00 p.m., then say, “Hey.  This is my lunch break.  Let me 
go eat some lunch.  Take ‘em.” Maybe I won’t go back to work.  Now, I’m in the 
bathroom, like, “Oh, God.  I feel like I gotta vomit.…” It’s just now I’m all in a frenzy… 
Where did all this stuff come from? The back of my mind.  My mind knew it was 
medication time. [Jada] 
 
Donna, a 33 year old Black woman diagnosed in 2008, planned to re-start ART again after a 
period of inconsistent adherence due to pill fatigue. Being offered a one-pill-a-day option 
(e.g., Atripla, Stribild) helped her feel able to commit to taking ART again: 
 
Donna:: My thing is I have a thing with a lot of pills.  If it’s two pills, three maybe I can do it 
but when it’s like six, seven pills I’ll be like, “No, I don’t feel like taking it today.”…At that 
time I was on a lot of different pills.  I’ll look at them, but I just won’t pick them up. …             
Interviewer: What goes through your mind when you’re looking at all the bottles. 
Interviewee: It’s like, “I’ll take them later.” 
Interviewer: When you were on it you said there were several pills.  How regularly did you 
end up taking it? 
Interviewee: Maybe like twice a week…I’m tired of taking pills.  I’m tired of having to eat 
before I take the pills, then they tell don’t take the pills right away.  Then you get an upset 
stomach.  I have this thing where I do not like when my stomach is hurting, I don’t like to feel 
nauseous all day, so after a while I just stopped…[my doctors] gave me some nausea 
medicine but it didn’t work… 
Interviewer:… So you think you might start medication again in the near future?...How do 
you think you’ll deal with the fact that it might be more pills? 
Interviewee: Thankfully it’s only going to be one… it’s just one pill and I can handle that.  
It’s just that more than one pill I can’t really. [Donna] 
 
Although not all people living with HIV are a good match for the one-pill-a-day regimen, 
those who had switched to this simpler regimen reported that a single pill (versus multiple 
pills a day) helped them consistently take their medication.  The challenges associated with 
taking multiple pills per day - e.g., pill fatigue, side effects, forgetfulness, trouble with 




For those who felt overwhelmed by receiving a month’s supply of ART, choosing to pick up 
their ART daily or weekly was an effective strategy that helped them adhere. Juan, a 49 year 
old Latino man, was diagnosed in 1984. He re-started ART the day of the interview, after 
being off ART for nearly a decade due to living in Mississippi, according to his interpretation 
(he stated that Mississippi did not provide HIV care to low-income residents who were 
reliant on Medicaid). Juan was concerned that having a month’s supply in his possession 
would tempt him to sell his medication, as he had done when he was prescribed ART years 
earlier. To avoid this temptation, he asked his patient navigator to arrange daily pick-up: 
 
Juan: The pharmacy they sent me to won’t give me the jars… Individual days.  Everyday 
I gotta go. 
Interviewer: [For] how long? 
Juan: Til I’m ready to take ‘em home that I know that I’ll take ‘em on my own.  I’m not 
ready for that yet.  I know that if they give me the jars, I’m gonna sell ‘em.  Oh yeah.  I 
made an agreement with [the patient navigator] that send me somewhere where I can get 
them already broken down…I said to her, listen.  Even though I’m 49 years old, I’m 
irresponsible, and I know that if they give me HIV meds, I’m gonna go sell ‘em.  Even 
though I get money, it’s just out of habit, you know?  “Well, we gotta place where you 
can go to, a pharmacy that will give you a weekly Metrocard every Friday.  You go 
everyday and take your meds.”  I said, “okay.” [Juan] 
 
Tina, a 53 year old Black woman quoted below, was diagnosed in 1995 and like many 
participants, had past struggles with pill fatigue, and forgetting to take her medication. 
She also did not want to receive a full month of HIV medication at a time. Her concern 
was not the temptation to sell her meds, as with Juan above. Rather, she found that a 
weekly pick-up enabled her to be mindful of her ART regimen, and avoid forgetting 
about the pills during the course of a busy or stressful day. Even though weekly pick up 
entailed traveling from Brooklyn to upper Manhattan, she preferred to obtain a less 





…I’ll be doin’ so many other things that I’ll just lay there and just won’t take ‘em.  I 
know what.  That’s why I like to come pick ‘em up [in Manhattan, from Brooklyn] once a 
week ‘cause then—…Because if I have so many pills, I forget.  If I got one case, I’ll keep 
lookin’ at that one case.  If I got all them cases…sometimes I’m just not thinking about it. 
[Tina] 
 
The different use- and adherence-related obstacles described above appeared to make 
people feel controlled and/or restrained by a daily regimen of ART. By devising 
strategies to overcome their respective challenges, participants were able to feel more 
agentic and capable of consistently taking their medication. As all participants in the 
study had been recently disengaged from outpatient HIV care (with some of them having 
successfully re-engaged or re-started ART at the time of the interview), problem-solving 
strategies were necessary in order to achieve their goals of remaining adherent to their 
medication regimen despite these challenges.  
 
Beliefs related to ART: The Effectiveness of the Current Therapies 
Participants’ ART-related beliefs revealed they recognized that HIV was a 
chronic illness manageable by consistent ART adherence. The majority of participants in 
this study had previously taken ART, either consistently or inconsistently, at some period 
in their lives; only a few had recently begun taking HIV medication for the first time. 
Many of the participants were long-term survivors, having lived with HIV for one or two 
decades or longer. Notably, all expressed an active commitment to remaining adherent to 
their ART regimens, or if still disengaged or not on ART, a strong desire to re-start HIV 
medication. All participants shared the belief that ART provided them with the 
opportunity for a longer, healthier life, and that without it, they would surely die. These 




desire and motivation to re-start it. Thus, affirming beliefs about the effectiveness of 
ART, in combination with other adherence-related strategies, appeared to help override 
the physical and mental challenges associated with taking ART.  
Many participants contrasted AZT-era medication with newer, more effective and 
less toxic classes of HIV medication. Luis, a long term survivor of HIV, remarked: 
 
… today, people are living much longer with the virus.  It’s not—I don’t see it as a death 
sentence no more.  I don’t.  The Center[s] for Disease Control said, it’s a chronic illness.  
To a certain degree.  I believe that too.  It’s a chronic illness.  Even though I still feel 
people are dying, but the extension of life has been prolonged because of the 
medication…I feel that due to the fact that people are living a lot longer with the virus, 
that they should take the medications. [Luis] 
 
Tanya, quoted below, was blunt in her assessment of the importance of taking ART: 
 
If you wanna live, just take your meds.  If you don’t wanna live, then—you ain’t gonna 
live if you don’t take your meds.  You have to take your meds.  You have to. [Tanya] 
 
Sandra, a 42 year old Black woman, diagnosed in 1993, was undetectable and adherent at 
the time of the interview. She had switched providers due to moving in the past few 
months, but was able to remain on ART consistently. Prior to re-starting ART two years 
prior to the interview, her Medicaid had lapsed and she stopped taking her medication. 
She expressed her happiness that effective medications were now available: 
 
The medication, it’s helpin’ me.  It’s not like it’s doin’ any harm to me.  It’s really helpin’ 
me, I would say, prolongin’ my life.  I know someday, I am gonna pass away, but it’s not 
today.  I’m really, really grateful for that because like I said before, back when people 
was taking AZT or when the virus first came out, people were droppin’ like flies.  They 
didn’t know what was goin’ on.  Just to see 26 years later, I’m still here.  [Sandra] 
 
Myra, a 44 year old Black woman who had been diagnosed in 2012, was undetectable at 




interview, she had become stably housed after being homeless for ten consecutive years. 
She attributed to her ability to begin ART for the first time and manage her HIV and her 
health to obtaining stable housing. Like Sandra above, she expressed gratitude that her 
diagnosis came after the AZT era of medication: 
 
Interviewer: Are you comfortable with taking medication? 
Myra: Yeah.  I’m cool with it.  I was told that I’m one of the lucky ones.  I got 
diagnosed…with HIV when the medication became better.  Before, 10 years before me, 
the medication sometimes was worse for patients than having the HIV itself.  A lot of 
patients didn’t like the medicine.  They would not take it because they would feel better 
with HIV without.  Now the medication is much better.  [Myra] 
 
For some, including both long-term survivors and those more recently diagnosed, 
re-starting occurred after being off ART for one or two years; for others, their periods of 
disengagement or inconsistent engagement were five, ten years or longer. However, 
regardless of how long they had been living with HIV, people differentiated the highly 
toxic and ineffective treatments of the AZT era from the currently available classes of 
ART; this comparison appeared to help them recognize and believe that HIV can be a 
chronic illness made manageable with consistent adherence.  
 
Theme 2: The role of providers in supporting ART use and adherence 
Participants’ descriptions of their experiences with and thoughts about ART naturally 
extended to discussing their past and present interactions with their HIV providers. 
Participants recognized, and greatly appreciated, providers that practiced patient-centered 
medicine. Two subthemes emerged as characteristics participants desired in their 
relationship with HIV care providers: 1) genuine concern; and 2) feeling heard 




subthemes reflect the core features of patient-centered medicine. Participants desired 
these characteristics in their relationships and interactions with providers, and providers 
who conveyed these attributes appeared to contribute to participants feeling comfortable 
and confident, particularly around the issue of taking ART. In discussing these 
interactions, participants were describing many of the tenets of patient-centered medicine. 
Having a provider that embodied these characteristics appeared to facilitate engagement 
in care, and more specifically, retention and adherence.  
 
The value of provider genuine concern 
Participants reported various types of interactions with HIV care providers. Some had 
been with the same provider for ten plus years, but were not on ART, while others had 
only recently engaged with an HIV provider on a consistent basis and were on ART. 
Regardless of whether their relationships with providers were long term or newly 
established, participants highlighted the importance of feeling that providers were 
genuinely concerned about them.  For example, Jay, a 31 year old Black man, was largely 
disengaged from outpatient HIV care and not on ART at the time of the interview. He 
was interviewed at his bedside while hospitalized for fatigue, shortness of breath, and 
“probably a little pneumonia,” in his own words. At the time of the interview, Jay had 
been hospitalized for similar reasons twice in the preceding two months. Although he 
expressed appreciation for the way in which his HIV doctor interacted with him 
whenever he visited her, he continued to struggle with accepting his status, “I don’t even 
wanna think about it … it makes me angry, so I really don’t wanna talk about it.” This 




appointments, although he stated that he planned to make a clinic appointment to see his 
provider after his hospital discharge. Jay’s doctor appeared to be at least one facilitating 
factor in his new “goal” to become healthy for at least the sake of his children, “I'm 
gonna do everything I need to stay around for my children. That's the goal, that's the main 
goal”: 
 
[Dr. S is] my best doctor…She did everything for me.  She lets me know what's gonna 
happen if I don't do this and don't do that.  She just talks to me where I don't have to talk 
back…She's smart.  She always helps me out.  Just looking after me. [Jay] 
 
Cee Cee also expressed why she was confident that her HIV doctor was genuinely 
concerned about her wellbeing:  
 
My doctor…She’s very—she’s into your health.  She called me late at night, gave me her 
cell number.  She made me go the hospital…my protein level was high, and my potassium 
was high.  This was about two weeks ago, or three—two or three weeks ago, I was in the 
hospital.  They kept me over night.  Then, they brought me back home cuz of the swellin’.  
I still get edema or whatever in my limbs.  She said, “Name.”  She thought I was gonna 
through a—she thought my kidneys were gonna stop workin’.  She made me go. She’s 
very concerned. [CeeCee] 
 
Similarly, Sandra, quoted below, described how her HIV doctor’s concern for her health 
conveyed genuine caring, rather than an interest in increasing patient “business”:  
 
I was sick one day, and she, my doctor, just wanted to just wheel me down the emergency 
room.  I was like, “No.  I’m okay.  I’m okay.  I’m okay.  I just need some rest.  I need to 
go home and rest.”  She’s like, “It’s up to you, now.  I’m your doctor, but I really can’t 
force you.”  I had a little abdominal pain, but it went away. She was so concerned.  When 
I got home that day, she called me, asked me was I all right.  That’s what also keeps me 
goin’ because there are people out there that really care.  They’re not people out there 
just wanna get in your business.  There are people that really care, and I think that she’s 
one of the doctors that do care. [Sandra] 
 




Related to the value placed on feeling genuinely cared for, participants also 
emphasized the importance of feeling heard by their providers. Feeling heard entailed 
feeling included in decisions about their care, especially ART-related decisions such as 
being given a choice or presented with options in terms of their regimen or discussing 
together how to select a regimen. These interactions made participants feel respected and 
promoted a sense of agency, a core feature of patient-centered medicine.  
 
We talk about everything, so I like her… Meds, my health, and what—how my viral loads 
go down and what makes ‘em go up and things I should do and shouldn’t do.  She’s 
nice…I feel like she’s honest.  I don’t know if she is, but she’s honest with me…She told 
me certain things, and I believe her.  I have no reason not to.  She’s my doctor.  She talks 
to me.  Most doctors don’t talk to you…none of them other doctors I had didn’t talk to 
me.  They just give me my meds and send me home, or take my pressure and stuff and 
send me home.  They don’t sit and listen to me. [Tina]  
 
In addition to feeling listened to, feeling heard as experienced through being given the 
opportunity to co-construct care was also valued: 
 
 [My provider]’s helpin’ me.  He changed my meds when I asked him to change my meds.  
I don’t have no problem with my doctor. [Tanya] 
 
Janae, a 43 year old Black woman, had been taking ART consistently for a month prior to 
the interview. She had recently switched to a new medication due to side effects, after an 
extended period of feeling ignored by her provider. She highlighted how coming to a 
point where they could “work together” on managing her ART issues with her doctor was 
essential to establishing a good relationship: 
 
Janae: … the [HIV] medication they kept puttin’ me on I kept gettin’ sick.  I was catchin’ 
stomach pains… catchin’ headaches, throwin’ up a lot.  Even if I drink water it’s like it 
was not holdin’ down… They said my T cell was getting’ low…everything was just like—
it was not even workin’ at all, at all.  I kept goin’ [to the doctors], “I’m not takin’ it,” 
because it give me night sweats, it make me have bumps and chills and everything.  They 




the meds.”… I’m not gonna keep takin’ somethin’ that’s gonna make me sick. I’m not 
gonna take it, you know?  I’d just rather leave it, leave it as is.  Sometimes I just felt like 
givin’ up ‘cause I’m like, “If y’all not gonna gimme no pills then just leave it.”  Just let it 
go, ‘cause I’m not gonna keep takin’ somethin’ and I’m gettin’ sick, throwin’ up all the 
time, not eating, not lookin’ like—not care for my children, not carin’ for myself or the 
household or anything.  This [new] pill is workin’.  …  
… 
Interviewer: Do you trust your doctor? 
Interviewee: Yeah, now I do.  At first I didn’t, because she didn’t give me the right meds.  
Now she find me the right one, because, I felt that you ain’t wanna help me.  I had that 
attitude that you did not want to help me….[The clinic] told me she was a good doctor… 
I’m not gonna down her.  She’s damn good…  When I come at you—I’m comin’ at you 
because somethin’ is not workin’.  Somethin’ is bothering me.  Don’t look at me and say, 
“Hmm, well maybe you’re not takin’ it right.”  I’m like, “You downin’ me?  You think 
I’m not takin’ my meds?  Okay, if you don’t trust me, I won’t trust you.”  That’s how I felt 
until we had that communication.  I’m like, “Okay, calm the attitude down,” and just tell 
her, “Well, okay.  This is how it is.”  I told her how it is and we was workin’ together.  
Ever since then I ain’t got no problems, no problems. [Janae] 
 
 
For Janae, perceiving her provider as not trusting her, or viewing her as a competent 
patient was initially extremely frustrating, but finally achieving “that communication” 
enabled Janae to trust her and facilitated her adherence. Janae’s use of the term 
“downing” to describe feeling disrespected also reflects her desire to share the power and 
to co-construct a collaborative, mutually respectful relationship with her provider. This 
collaborative relationship reflects one of the core tenets of patient centered medicine, 
which is for providers to respect and respond to patients’ concerns. Specifically, her 
doctor’s recognition that Janae was having a very difficult time living her life as a mother 
suggested a patient-centered relationship. 
 
Terrence, a 39 year old Black man, was diagnosed in 1989 as a young teenager, but had 
only sought care in his early 30s, having remained relatively healthy until 2007, when he 




clinic very infrequently, and not being able to continue his ART consistently.  He 
attributed his lack of adherence to the “regimented” nature of having to take his 
medication every day to avoid becoming resistant, and his lack of consistent clinic visits 
to his good health that lasted from his early teen years to his early 30s. Terrence 
contrasted his current situation with his past negative experience with a provider. Again, 
this was expressed in terms of ART options, suggesting that choice, agency, and an 
atmosphere of collaboration were highly valued. He contrasted his past provider to his 
current as follows: 
 
I think it was his workload.  I think a lot of it was just it became a generalization.  It 
became seeing patients, patients, patients, and not having the time to separate and say, 
“Hey, wait.”  I don't think he had the time for that.  It was like, “Hear me out and listen 
really well.  Take notes and everything.”…My [current] doctor, she'll give you the [HIV 
medication] options and say, “Look.  I think this,” and get insight from me, and see what 
my thinking is.  “How do you feel about that?  What's gonna work for you and the 
dogs?” It's more in depth.  It's more personable, if you will… No, it wasn't about that for 
my [previous] doctor.  It was about, “We're gonna see what works for you.”  For me, 
that was huge, seeing that actually happen.  Not her keeping her word, but being just 
really consistent… To have someone who's real steadfast and really in the middle, 
whether it be my doctor, or my mother, or my partner.  It gives me a lot of comfort… 
Yeah, she gave me my options and went over my labs with me.  When something's good, 
she—not like makes you feel more good than you need to, but you can hear the genuine, 
“Okay.  We got this.  We're on the right path.  Keep it up.  You're doing good,” sort of a 




Here, Terrence’s provider demonstrated to him that she was interested in his “insight”, 
and was genuinely thinking about to the significant role of his dogs into his life. This 
participant’s main source of strength and support were his two small dogs, Trixie and 
Pixie. Terrence almost had to give up Trixie and Pixie due to his previous housing 




This reflects how Terrence’s doctor saw him as a person not just a patient, which is 
another feature of patient-centered medicine. 
 
In contrast to Terrence’s provider who was highly responsive to the most salient aspects 
of her patient’s life, Pablo, quoted below, explained how some providers fail to convey a 
feeling of genuine concern by appearing inaccessible, or failing to work with the patient 
to jointly arrive at a solution. Pablo, a 46 year old Latino man, was diagnosed in 2001 and 
had been enrolled in an outpatient methadone clinic for one week at the time of the 
interview. He “got in[to drugs] at 12 years old”, and had since been struggling with 
staying sober. At the time of the interview, he felt he was “dying” and needed to 
immediately start taking care of his health, which required him to begin to manage his 
substance use. Like many of the participants, Pablo had multiple comorbidities, including 
hepatitis C-related cirrhosis and diabetes. He had not been on ART for at least the prior 
seven months (partially due to a paperwork lapse in his Medicaid, but also due to 
substance use challenges), but expressed a determination to re-start ART, “I’m suffering 
a lot… I have to start on my medication back. The first thing I’m gonna do, get my 
medication…” Pablo described the characteristics he appreciated in a provider, as well as 
expressed frustration at doctors that appeared to not genuinely care or listen to their 
patients: 
 
…You got [to have a] doctor that take the time to talking to you. You got doctors that 
not…You see some doctors, they’re not worried about you. They don’t really want to 
work. They no worry about you. They don’t have time to ask the questions about it. They 
gonna tell you whatever he want to say. They’re not looking for some solution that you 
really want ... They respond, [but] you can’t say, “Okay, I’m positive. I can’t do this. I 





In Pablo’s experience, a provider that is, “gonna tell you whatever he want to say” as 
opposed to opening a dialogue with the patient suggests that she or he is not -committed 
to working with the patient, and more specifically, to “hearing” the patient’s concerns 
and opinions.  
 
Aliyah, a 28-year old Black woman, also reported that she was interacting with a provider 
that did not appear to be interested in “hearing” her concerns. Aliyah, born with HIV, had 
been adherent to her HIV medication (one pill a day for the last year), but had been 
avoiding her HIV care provider around the time of the interview. She had been recently 
transferred from the pediatric HIV clinic to the adult clinic, and explained that she felt 
forcefully transitioned against her wishes. During the six months prior to the interview, 
she had been hospitalized six times for potassium-related issues. Aliyah largely attributed 
her inconsistent, precarious engagement, i.e., not attending regularly scheduled 
appointments and only going to see her HIV provider if she had a non-HIV related 
problem, to the way in which her care was transferred from pediatric to adult care, as well 
as her provider’s apparent lack of concern about her drastic weight loss: 
 
I was in [the pediatric HIV clinic] and then they basically told me when I was in the—I 
was in the hospital that they made me an appointment with this [new doctor at the adult 
HIV clinic].  I basically had no choice but to go to him.  That’s what I felt.  Now I feel 
like I’m stuck with this doctor...the last time I did the interview I had to be about maybe 
180, 170 [pounds].  Right now I’m 114.  That’s a lot of weight to lose and not try to lose 
it.  It’s just coming off and just because I’ve been under a whole lot of stress…My doctor 
that I have now doesn’t—like he tells me that it’s the medicine.  Basically if I take the 
medicine I’ll gain weight.  That’s what I’ve been doing.  I’ve been doing the medicine but 
I’m still losing weight, and he doesn’t want to do anything about that…. Personally I feel 
like he’s just telling me what the—I guess what the doctor books say, you know, “Just 
take your medicine and you’ll be okay,” but it’s not—I’m still losing weight and no 
matter how much I eat… That’s why I really don’t like him too much.  Any times I do go 




went to him.  I really don’t go to him for my other stuff that’s going on.  I don’t do it.  It’s 
something physically wrong with me, like my foot hurts or my back is aching, I might go 
to him to try to fix it.  Dealing with the HIV, I don’t go to him for that. 
[Aliyah]  
 
Overall, the value placed on feeling heard, which entailed not only being listened to, but 
having one’s opinions solicited and taken into consideration, largely was expressed in the 
context of ART and making ART-related decisions. In addition to ART decisions, 
participants also discerned and desired the following features of patient centered 
medicine: being seen as a person, not a just a patient; their provider engaging in 
communication and behavior that allows a more equitable distribution of power; and 
establishing a therapeutic alliance. Underlying these subthemes was the value participants 
placed on feeling genuinely cared for by their HIV care providers, which was 
underscored by being included in important decisions about their care, a process that 
engendered patient agency.  
 
Discussion  
People’s ability and desire to engage or re-engage in care and/or re-start ART 
varied and depended on multiple factors, structural (e.g., housing, benefits’ eligibility, or 
access to substance use treatment), interpersonal (e.g., primarily relationship with HIV 
provider), and intrapersonal (e.g., acceptance of one’s serostatus or use of substances). 
This paper focused on just a few of these interconnected factors: contending with non-
side effect related ART challenges, positive beliefs regarding ART, and experiences with 
providers. The physical aspects of ART-related challenges included difficulties taking 
their medication, such as an aversion to swallowing pills. Psychological obstacles 




reminded of one’s seropositive status. There was often an overlap between physical and 
psychological barriers. For instance, overcoming a swallowing issue is both physical and 
mental by nature and necessitates thinking about and employing strategies to manage or 
overcome both aspects of the problem (e.g., changing to one-pill-a day regimen and 
working to accept one’s HIV status and the need to take medication). Most common 
strategies to manage these barriers included changing medications to avoid or decrease 
side effects (e.g., changing from a multi-pill to a one pill regiment), devising routines that 
mitigated the challenges (e.g., enrolling in an adherence program to remain motivated to 
adhere or address forgetfulness), and generally trying to understand the underlying causes 
of their particular obstacles (e.g., recognizing that a monthly supply of ART generated 
the temptation to sell them and using the money to engage in substance use).  
Control over health seemed to symbolize or connote control over one’s life, a 
notable finding given how socioeconomically disadvantaged the participants were, and 
how limited control they had over most domains of their lives. Here, Cockerham’s theory 
of health lifestyles is useful for illuminating the interface between structure and agency 
[22]. Informed by Bourdieu’s concept of habitus [23], this sociological theory highlights 
the relationship between structure and individual agency, and postulates that structure 
(defined as life chances) and agency (defined as life choices) interface and produce a 
person’s habitus. This framework renders visible the complex ways in which people’s 
health dispositions (health habitus) and practices are influenced by social structure.  In 
particular, social structure deeply influences people’s experiences with the health care 
system and their health-related decision-making and behavior, including disengagement 




lifestyles [22]. Importantly, these findings suggest that when offered opportunities, 
participants who in the larger socioeconomic context have been deprived of agency, were 
able to develop strategies to improve their ART adherence, and to participate and desire 
patient-centered care.  For example, by effectively addressing the obstacles to ART 
adherence and experiencing improved health, participants expressed feeling more in 
control of their illness and lives. Similarly, having positive beliefs about the medication 
efficacy helped facilitate their adherence, or their desire and motivation to re-start it. 
Therefore, a type of latent, but significant outcome of adherence to treatment for 
participants, was a strengthening of their agency. Affirming beliefs about the 
effectiveness of ART, in combination with other adherence-related strategies, appeared to 
help override the physical and mental challenges associated with taking ART. These 
findings support previous research that has suggested agency, often measured as self-
efficacy in public health, is conducive to ART adherence  [24,25,26].  
Having a provider that practices patient-centered medicine appeared to help 
participants contend with their respective ART challenges, and this also strengthened 
participants’ agency [27].  Participants discussed the importance of having a provider that 
makes them feel genuinely cared for, and respected, which was often expressed as feeling 
heard and making joint decisions regarding ART regimens and other aspects of their 
health care. These provider-patient relationship characteristics reflect the model of patient 
centered medicine. These findings affirm previous studies that have emphasized the 
importance of patient-centered medicine in the context of HIV care [28-31]. For example, 
a 2013 study found that feeling "known as a person" by their provider was a facilitating 




very similar to the context and data presented here that emphasized the importance of 
patients "feeling heard" by their providers. 
It is significant that participants recognized who practiced this type of medicine, 
and that their provider doing so facilitated their ability to engage and adhere consistently. 
In particular, the issue of jointly choosing a regimen, or being offered treatment options 
and being invited to choose a regimen with one’s provider, was highly valued as a 
signifier of respect and collaborative care, the kind of care that bestowed dignity to the 
patient and bolster his or her agency. Importantly, although most participants reported 
having access to social workers, case managers and other clinicians, they largely 
emphasized the importance of their HIV care physician in terms of their adherence. This 
in part could be due to the physician’s role in changing their ART regimens. Thus, even 
though many participants experienced clinical team-based care, the unique importance of 
their HIV care doctors stood out as highly salient.  
Given the salience of the challenges posed, whether physical or emotional, the 
experience of being given choices, and perceived as a partner in care, appeared 
transformative in helping people feel confident and optimistic about being able to adhere. 
Overall, these findings suggested that the presence of these interpersonal facilitators 
engender agency, motivate and support people to remain engaged in care and adherent to 
their ART.   
Limitations and challenges 
The study presented here utilized purposive sampling to enroll 27 HIV-positive 
participants, and had been recently, or were currently, disengaged from outpatient HIV 




thematic saturation was achieved with the completion of 27 semi-structured interviews. 
Additionally, the sample enrolled participants that were at various stages in their re-
engagement process, thus making this sample is a good reflection of the larger population 
of low-income people of color contending with engagement and adherence challenges. 
While some had successfully become re-engaged and consistently adherent to their ART 
regimens after periods of disengagement and/or non-adherence, most participants were 
still contending with challenges related to consistently engaging and adhering. It is 
important to note that all participants in the sample had been disengaged from outpatient 
HIV care within at least one to three years prior to their interviews; thus, this study was 
able to explore the challenges related to engagement and adherence among a group of 
people that were either currently struggling with consistent engagement and ART 
adherence, or had recently managed to re-engage or re-start ART. 
This study also sought to differentiate the operationalizations of engagement and 
adherence in regard to the quantitative data and the qualitative data. The survey’s 
response choices for the items that were used to evaluate engagement and ART 
adherence were limited to fixed categories, which appeared to have inadvertently resulted 
in a social desirability bias. The combination of the instrument design-related bias and 
social desirability bias appeared to have resulted in a higher percentage of participants 
reporting they regularly attend clinic and consistently take their ART than was actually 
the case, as discerned during the in-depth portion of the interview. Thus, some 
participants’ quantitative data did not neatly match the survey data provided during the 
semi-structured portion of the interview. However, it is likely that the social desirability 




built between the interviewer and participant over the course of the qualitative portion of 
the interview. Moreover, qualitative probing allowed for participants to provide nuanced 
responses to questions regarding their experiences with disengagement and re-
engagement and adherence challenges.  
Finally, although the topic of “conspiracy beliefs” is often regarded as 
controversial or even taboo, thus possibly increasing the likelihood of desirability bias, 
the interviewer took special effort to avoid introducing pre-judgments about participants’ 
beliefs and experiences. In order to provide an open, non-judgmental environment, the 
survey did not include items these kinds of beliefs, thus allowing the topic to emerge as 
organically and neutrally as possible during the course of the semi-structured portion of 
the interview. Participants often raised the topics themselves, but in absence of that, the 
interviewer employed neutral language to inquire about beliefs regarding the efficacy of 
ART, the possibility of a cure, the role of the government, if any, in the epidemic, and the 
nature of the possible origin of the HIV. These strategies, in addition to the extensive 
training the interviewer underwent on how to elicit sensitive information, reduced the 
potential for social desirability bias, and encouraged participants to speak openly about 
their HIV-related beliefs and their experiences with HIV care.  
 
Recommendations 
Interventions at the provider-patient level can foster trust and help patients 
internalize the belief that engagement in care and consistent ART adherence renders HIV 
a chronic, manageable disease. Related, participants’ emphasis on wanting to manage 




not only lowering viral loads and achieving viral suppression, but also in helping patients 
feel agentic and able to remained engaged and adherent to their ART. HIV providers that 
communicate genuine care, concern and respect for their patients and that strive to 
involve patients in their care and thus recognize them as people with agency have the 
potential to reverse these negative patient emotions that undermine their engagement in 
care. Thus, HIV care providers most often serving as primary care physicians for their 
patients and playing many different supportive roles beyond the clinical, are uniquely 
situated to work closely with patients to effectively face engagement challenges together.  
Making people feel worthy of care and agentic was one way in which providers 
contributed to people’s ability and desire to manage their HIV. In general, many factors 
coalesced to influence this ability and desire, but the management of mental and physical 
barriers posed by ART, and negotiating ART decisions/changes with providers, was more 
likely to be successful if all of these components were present. Participants’ experiences 
with and reasons for engagement were varied, but the issues of effectively managing side 
effects and other pill-related barriers, having positive ART-related beliefs, and 
developing collaborative relationships with their providers were revealed to be highly 
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Summary of public health and sociological approaches to understanding “conspiracy 
beliefs” 
Prior to the start of the study, an extensive literature review was conducted in 
order to map out both the theoretical positions on and empirical knowledge about the 
phenomenon of health-related “conspiracy beliefs”, with a particular interest in those 
ideas and beliefs that pertain to HIV. There are numerous empirical studies that test the 
association between health-related and specifically, HIV-related “conspiracy beliefs” and 
a variety of health behaviors and outcomes, including birth control use, HIV testing and 
treatment practices, and participation in biomedical research. I was particularly interested 
in the way in which public health, as a body of literature, framed HIV-related “conspiracy 
beliefs” as a type of medical mistrust that developed in the shadow of the Tuskegee 
study, and to a lesser but still key extent, slavery in the United States. For public health 
researchers, these types of ideas and beliefs are conceptualized as manifestations of 
primarily historical racism. 
       Although the public health literature predominantly focuses on the role of the 
Tuskegee study in causing race-related medical mistrust [1-2], the sociological literature 
locates phenomenon in a racialized context, Waters (1997) notes “conspiracy theories 
held by African Americans that seek to explain ethnic inequality are intrinsically 
interesting as a subset of conspiracy theories because they may indicate areas of 
tremendous uncertainty in interethnic relations. In addition, they may shape behavior by 
providing parameters for political and social action in racial conflicts. In short, 




directions of interethnic interaction.” [3] Waters’ analysis suggests that “conspiracy 
beliefs” held by African Americans may represent manifestations of the various ways in 
which society is shaped by rigid, interlocking structures of racism, sexism and classism. 
Similarly, Mackenzie argues that “conspiracy beliefs” should be reframed as “counter-
narratives”, which serve to “create a rhetorical space for challenges to power through the 
articulation of oppositional ideas about dominant scientific knowledge.” [4] Recently, 
Heller (2015) posits that HIV-related “conspiracy beliefs” are not in fact rooted in 
ignorance, but can be better understood as the "1) result of historical experiences that 
have engendered distrust, 2) a result of continuing distrust, and 3) an indication of social 
anxieties associated with the HIV/AIDS epidemic, drug use (as a source of HIV and as an 
arm of the genocide attempt), and African American's place in American society" [5]. 
Heller considers such beliefs are a “measure of trust” between African American 
communities and the health care system. Although some studies have suggested 
education as a means of dispelling “conspiracy beliefs”, Heller notes that increased 
knowledge will “work only if people trust the sources of official information", which 
often comes from government agencies such as Centers for Disease Control and 
Prevention, or state health departments.  Therefore, “conspiracy beliefs” can also be seen 
as a “measure of trust” between African American communities and the government in 
general [5].  
One purpose of the present investigation was to obtain a more nuanced 
understanding of the nature of people’s beliefs, and to tease out how endorsement may 
(or may not) affect people’s engagement in care, particularly among a group that was 




interviewed for this study). Qualitatively exploring this issue facilitated the emergence of 
diverse variations of so-called “conspiracy beliefs.” Regarding origin-related beliefs, 
some participants strongly expressed their belief that the government and/or the 
pharmaceutical industry deliberately created HIV to target racial and ethnic minority 
populations (and occasionally, substance users or gay men). Others strongly criticized 
these origin-related ideas, and vehemently disagreed with the underlying assumptions of 
deliberate genocide.  
For some participants, the discussion of both origin and cure-related ideas elicited 
a dismissive reaction: “It doesn’t matter where it came from, I have it [HIV].” This 
straightforward response was often accompanied by a dismissive attitude about whether 
or not they believed these ideas were true. These dismissive dispositions were interpreted 
as avoidant, as participants in this subgroup did not focus on whether or not they believed 
such ideas, but rather, were quick to express that they were, unwilling to invest energy 
and time to even contemplate the veracity of the ideas. Importantly, endorsing these 
beliefs – or merely contending with them and thinking about them— did not appear to be 
a direct driver of disengagement or barrier to re-establishing care or re-starting an ART 
regimen. Rather, for the engaged and the inconsistently engaged/adherent participants, 
endorsing or not endorsing “conspiracy beliefs” was not a significant factor in their 
adherence or retention, while those who were still disengaged at the time of the interview 
appeared to be dismissive and/or avoidant. For the latter group, being avoidant or 
dismissive – even when acknowledging some of the ideas may in fact be true- suggested 
a realization that contended with these kinds of beliefs could potentially be destabilizing 




unstability, for instance, in terms of their housing situation or related to their substance 
use and described lives particularly insecure and anxiety provoking.  This avoidance 
could thus be interpreted as signaling powerlessness, but also perhaps resistance to 
expending emotional energy dwelling on a fundamentally unjust society. This resistance 
could signify a refusal to allow their health to be further derailed by the power complex.  
For these dismissive participants, the daily reality of living with few financial and 
social resources and trying to manage HIV was far more pressing than investing time 
thinking about the possibly nefarious origins of HIV. In fact, many participants did not 
seem to even want to contend with or entertain these thoughts and avoided assigning any 
significance to “conspiracy beliefs” and allowing them to influence their lives, even when 
some of them seemed to endorse or almost endorse some of the ideas.  
Participants’ narratives illuminated both the targets of the conspiracy (poor 
minority people) and the conspirators (the government-pharmaceutical complex) in each 
scenario. Endorsing ideas about government or scientific conspiracies was found to be 
associated not only with race, but also with socioeconomic status. This is an interesting 
finding, as the public health literature closely links health- and HIV-related “conspiracy 
beliefs” with race (perhaps more specifically, racism stemming from historical 
injustices).  In this sense, these narratives offer an intersectional understanding of these 
beliefs by highlighting not only racism, but also poverty-based exploitation (i.e., 
classism) by the government-pharmaceutical industry power complex.  
For many participants, pharmaceutical companies represented “big business”, and 
were perceived as reaping big profits from the sale of ART. Therefore, it seemed obvious 




“big business” to imply that pharmaceutical companies and the federal government are 
chiefly concerned with realizing big profits, in a manner that is unethical and even 
beyond the law. These sentiments culminated in a widespread belief that a cure does 
currently exist, or a cure may very well exist, and is being withheld or will be withheld if 
discovered in the future, from poor patients, like the participants covered by Medicaid. 
Thus, participants’ self-identification as poor – typically described as being eligible for 
Medicaid benefits—was an important aspect of contextualizing their beliefs.  
Many argued that the drug companies are exploiting them by charging their 
insurance thus generating profit for the amorphous pharmaceutical industry. Participants 
placed the government and the pharmaceuticals on the same side and did not discuss the 
main contradiction in their argument, that is, that the government pays for their Medicaid 
insurance and therefore, the pharmaceuticals also exploit the government. This 
contradiction was not perceived by participants, as they generally believed that the 
government colluded with drug companies to make “billions”, and thus profited as well. 
Thus, these beliefs reflect a systematic exclusion from life opportunities rendered visible 
by the ways in which participants defined the powerful in our society. Moreover, 
participants largely expressed these beliefs in a racialized context. Thus, the perceived 
socioeconomic exploitation and discrimination was intertwined with racial exploitation 
and discrimination. 	
Participants were also eager to share and discuss their struggles with taking ART 
consistently. Being able to take ART consistently required them to confront both physical 
and mental challenges, both of which, if managed effectively, helped them achieve 




The physical aspects included contending with difficulties taking the pill[s], such as 
having an aversion to swallowing pills. Psychological obstacles included pill fatigue, or 
having negative associations with pill-taking, e.g., being reminded of one’s positive HIV 
status. Both types of barriers- and there was often an overlap (e.g., overcoming a 
swallowing issue has both a physical and a mental component)—necessitated thinking 
about and employing strategies to overcome these various challenges. Strategies to 
manage these barriers included changing medications to avoid or reduce the negative 
effects (e.g., changing from a multi-pill to a one pill regiment), devising routines that 
mitigated the challenges (e.g., enrolling in an adherence program to remain motivated to 
adhere or prevent forgetfulness), and generally trying to understand the underlying causes 
of their particular challenges (e.g., recognizing that a monthly supply of ART generated 
the temptation to sell them and engage in substance use, or trying to reflect upon the 
reasons why they have not accepted their positive status). 
         By effectively strategizing and addressing their respective obstacles to ART 
adherence, participants expressed feeling more in control of their illness, and thus their 
lives. Control over one’s health seemed to gauge control over one’s life, and having 
positive ART beliefs contributed to this sense of agency and resilience. Importantly, all 
participants believed that ART, particularly in comparison to AZT-era medication, makes 
HIV a chronic, manageable disease. Thus, having positive beliefs about the medication 
efficacy helped facilitate their consistent ART adherence, or their desire/motivation to re-
start the medication treatment. Ultimately, affirming beliefs about the effectiveness of 




adherence, appeared to help mitigate the physical and mental challenges associated with 
taking ART. 
Participants also suggested that HIV care providers can be a trusted source of 
health information, and more importantly, hope and support in protecting or regaining 
one’s health. Thus, participants’ emphasis on wanting to manage ART-related challenges 
with their providers suggests that the HIV provider can play an instrumental role in 
lowering viral loads and achieving viral suppression via helping people accept their HIV 
and having to take ART for the rest of their lives. Accomplishing this type of relationship 
was accomplished by co-constructing a patient-centered relationship with one’s doctor. 
HIV providers that communicated genuine care, concern and respect for their patients 
and that strived to involve the patient in his or her care and thus recognized the patient as 
a person with agency had the potential to reverse these negative emotions that 
undermined participants’ engagement in care. In most cases, providers emerged as a 
source of treatment and illness information that participants trusted and this in all 
likelihood accounted for the fact that regardless of whether they endorsed or not the 
treatment-related “conspiracy beliefs”, participants recognized that ART made HIV a 
chronic, manageable illness. Thus, HIV care providers, most often serving as primary 
care physicians for their patients and fulfilling many different supportive roles beyond a 
clinical scope, are uniquely situated to both accompany and work closely with patients to 
effectively face adherence and engagement challenges as a team. Thus, consistent with 
the literature on patient-physician relationships [6-8], the data also suggests that HIV care 
providers have an opportunity to have an extremely meaningful role in their patients’ 




articulate the traits they hoped to find in a future provider. These same kind of 
characteristics, which describe the core features of patient-centered medicine, were 
discussed by those participants who reported having providers that helped them remain 
engaged and adherent. Overall, while many factors coalesce to influence the ability and 
desire to engage, the management of mental and physical barriers posed by ART, and 
especially negotiating ART decisions/changes with patient-centered providers, were 
facilitating factors for people re-engaging in care, or remaining consistently engaged in 
care and adherent to their ART.   
 
Theoretical approaches to contextualizing the data 
There are a few theoretical approaches that are particularly useful for 
contextualizing the data sociologically. Bourdieu’s concept of habitus, as theorized in the 
context of health lifestyles by Cockerham, as well as Garfinkel’s concept of cultural 
dope, and Foucault’s notion of bio-citizenship, are lens with which we can use to zoom in 
on the sociological meaning of these HIV-related origin and treatment beliefs.  
	
Bourdieu’s habitus and Cockerham’s theory of health lifestyle 
Cockerham’s theory of health lifestyle proposes that gender, social class and 
race/ethnicity are among the primary facets of the social structure that deeply influence 
people’s experiences with the health care system and their health-related decision-making 
and behavior, including disengagement and ART non-adherence [9]. Informed by 
Bourdieu’s concept of habitus [10], this sociological theory highlights the relationship 




chances) and agency (defined as life choices) interface and produce a person’s habitus. 
Therefore, this theory renders visible the complex ways in which people’s health 
dispositions (health habitus) and practices are influenced by social structure. Moreover, 
the theory postulates that the historical and collective experiences of social groups 
(including racial and ethnic groups, as well as other socially marginalized populations) 
also shape their habitus. Over time, health practices become solidified into health 
lifestyles [9].  
These complex processes make one’s habitus a durable and hard to change feature 
of one’s disposition and behavior; this analysis suggests that the nature of so-called 
“conspiracy beliefs” is part of this durable disposition individuals have towards their 
health and life. For example, contextualized within the long histories of vulnerable 
populations and minority groups’ social, economic and symbolic exclusion, research 
abuse and ongoing discrimination can easily account for the construction and the durable 
nature of HIV-related “conspiracy beliefs.” For groups that have been historically 
marginalized, the notions that the government is deliberately infecting them with the HIV 
virus, experimenting on disempowered groups, and/or is withholding a cure in order to 
profit and perpetuate their marginalization become less of an unreasonable system of 
beliefs. In fact, this system of beliefs might be an accurate representation of the social, 
economic and symbolic exclusion of the groups that find themselves at the lower ranks of 
the race and class hierarchies. 	
Garfinkel’s cultural dope  
The data provide an opportunity to reframe how we think about “conspiracy 




mindlessly reproduce social norms- is useful for drawing attention to a more nuanced 
understanding of the meaning of origin- and pharmaceutical-related beliefs among low 
income people of color.  Rather than approaching these ideas as irrational ideas to be 
debunked or dispelled, participants’ narratives revealed how they are not in fact cultural 
dopes. Instead, they provide an account of the perspectives of people who are often made 
powerless by intersecting structures of racial and socioeconomic inequality. Rather than 
being cultural dopes- specifically minority cultural dopes that endorse stereotypical, 
paranoid tropes associated with racial and ethnic minority groups- participants were 
largely reflective and articulate about their own lived experiences as persons with HIV. 
Foucault’s bio-power and being a good bio-citizen 
Applying Foucault’s notion of bio-power to these findings helps illuminate how 
people may demonstrate resilience and agency via the close management and 
surveillance of their health. Bio-power, Foucault's the idea that nation-states regulate the 
bodies of its citizens via a variety of techniques [14], is particularly applicable to 
management of one's HIV, which requires extensive self and provider/system 
surveillance to be managed effectively. The data suggest that successful re-engagement 
and retention may entail acceptance and desire to play the good bio-citizen role. Even 
though the participants acknowledged that they, as a socially and economically 
marginalized subgroup of color, are largely excluded from the social contract (both 
historically and presently), being a good bio-citizen was the only path to feeling healthy. 
Participants chose to focus on personal accountability as a way to exercise agency over 
their health, and to feel agentic and empowered by their decision to re-engage in care and 




one of the few domains in which they have some control and they exercised it; this is in 
sharp contrast to the powerlessness embedded in origin and pharmaceutical/cure-related 
beliefs. That is to say, participants expressed motivation and a desire for being 
accountable for managing their HIV and their health, even if they held worldviews that 
were rooted in deep suspicion and mistrust of the power complex.  	
Future research and recommendations 
 It is of considerable public health importance to more critically approach how 
HIV-related beliefs, particularly origin- and pharmaceutical-related ideas, are shaped by a 
combination of historical, social and economic influences. Public health, as a field and as 
a body of literature, over-emphasizes the role of the Tuskegee Syphilis Study, which 
makes it difficult to critically integrate theoretical approaches that connect mistrust not 
only to ongoing racial inequality and classism, but to experiences and perspective on 
powerlessness and social exclusion. The dominant public health discourse about 
“conspiracy beliefs” evokes misunderstanding on the part of the believers, or worse, 
paranoia and irrationality, thus discrediting the social groups (racial minorities of low 
SES) that hold such beliefs.  
Making rhetorical space for reframing these ideas necessitates a shift in the 
language we use to describe them. Although widely used in the public health and medical 
literatures, the term “conspiracy beliefs” is problematic and needs re-framing in order to 
reposition how we understand both historical and ongoing racism and classism as 
fundamental causes of social and health inequalities. The use of the phrase “conspiracy 
beliefs” should be discontinued in favor of more precise terms that describe people’s 




descriptively- for example, as HIV origin-related beliefs, or pharmaceutical/cure-related 
beliefs, they can be viewed less as irrational, and more clearly as possible manifestations 
of people’s perspectives and experiences living in a social structure that is shaped by 
racism and classism (and of course other forms of intersecting inequalities, such as 
sexism and homophobia), thus fostering ideas from the margins. 
 Ultimately, the data suggested that providers had the potential to be a significant 
and meaningful source of not only trusted health information, but also hope. Making 
people feel worthy of care, and agentic, was one way in which providers contributed to 
people’s ability and desire to manage their HIV. Pharmacies and hospitals were 
sometimes included in this government-pharmaceutical complex, but rarely HIV care 
physicians. This is likely because participants did not perceive their providers to be 
profit-driven or to benefit unethically from their prescribing ART. Thus, greed and 
dishonesty were necessary characteristics that defined the conspirator complex, and 
providers were largely viewed as not possessing this kind of exploitative power. Further 
research on the patient-provider relationship, particularly from the perspectives of 
providers themselves, would elucidate how HIV care physicians think about and 
approach these ideas with patients, and help inform public health efforts to support 
agency and resilience among populations that are socially marginalized. 
 
Summary of specific recommendations for public health interventions seeking to improve 





1) Developing interventions that focus on providers and patient-provider relationships, 
rather than “educational” interventions that aim to specifically dispel or dislodge so-
called “conspiracy beliefs.” The data suggested that people can endorse these kinds of 
beliefs and still successfully re-engage in care and consistently take ART. For example, 
efforts on the part of providers to foster positive ART beliefs, e.g., messaging about how 
while there is not a cure currently available, ART is a very close second, and conveying 
to patients that they are receiving the best medication that has ever been available to treat 
HIV. Since Magic Johnson has become a symbol of the withheld cure, messages that 
indicate that patients are offered the same medication that Magic Johnson takes, can also 
be strategic.  
 
2) Changing people’s attitudes toward ART is more feasible than trying to convince that 
the government did not in fact create HIV to target poor people of color. Indeed, 
participants indicated that they were educated about HIV (e.g., they had knowledge about 
T-cells and viral load as indicators of disease severity, resistance to medication if non 
adherent and other aspects of the disease). Thus, fostering positive beliefs about ART 
may be more helpful than attempting to dispel “myths.”  
 
3) Cultivating a patient-centered relationship. This would entail, for example, offering 
choices whenever possible about ART decisions to counteract the idea of “just pushing 
Merck.”  Based on the patient-centered medicine model [15], providers have the potential 
to establish a therapeutic alliance because they have earned most patients’ trust that they 





4) Related to fostering a therapeutic alliance, providers should take care to differentiate 
themselves from pharmaceutical companies. This includes not giving visual cues such as 
using pharmaceutical company pens and notepads, or recommending a particular 
medication without a clear explanation of why they feel that option is the best one for 
their patient. Participants generally did not seem to include providers in the government-
pharmaceutical industry scheme, so further reinforcing this distance would be beneficial.  
 
5) The finding that participants were very eager to play the role of a good bio-citizen can 




       Although public health often promotes social determinants models, the issue of 
“conspiracy beliefs” has not been framed in this way. I suggest that sociological 
frameworks can contribute to helping researchers and public health practitioners 
understand the impact of population-level material inequality on health dispositions, 
behaviors and outcomes. Specifically, a more nuanced approach is needed that considers 
how people, as individuals but also as members of groups, experience and interpret social 
and economic exclusion and injustice, and how this may influence their health behaviors. 
Cockerham’s theory of health lifestyles, as informed by Bourdieu’s concept of habitus, is 
particularly useful for changing the lens through which we try to understand both the 




everyday lives. Further, despite their place at the lower ranks of the race and class 
hierarchies, persons with HIV are the opposite of cultural dopes, they are thoughtful and 
strategic about protecting their health and prolonging their lives. Finally, contrary to the 
current discourse on “conspiracy beliefs”, persons with HIV seem to have a desire and 
motivation to be good bio-citizens, despite or maybe because they had been deemed 
unproductive or irresponsible citizens due to their poverty and lifestyles that contributed 
to becoming HIV positive.  Moving forward, creating rhetorical and intellectual space for 
simultaneously expanding and refining our understanding of this phenomenon can help 
inform interventions that seek to improve outcomes related to the HIV care continuum. In 
this sense, addressing material inequality alone, or attempting to “re-educate” people, is 
insufficient to address the complex roles of racism, discrimination, political exclusion, 
and systemic poverty in creating the conditions in which structural inequality has shaped 
many of the environments in which socially and economically marginalized people live. 
Although the participant narratives presented here speak to life on the margins, they also 
suggest a genuine and resilient desire successfully manage HIV- and be healthy and 
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Bedside to Community (B2C) engagement criteria  
 
Sample Eligibility: To be eligible individuals must: 1) be age 21 or older; 2) self-
identify as non-Hispanic Black or Hispanic (of any race); 3) self-identify as HIV-
positive; 4) be confirmed as HIV-positive based on medical record; 5) report having been 
diagnosed with HIV for at least two years; 6) be currently hospitalized in the CUMC 
Adult AIDS unit; 7) have their most recent CD4 cell count under 350 based on medical 
record; 8) report that they have not seen any HIV outpatient clinician for at least 6 
months. Patients will be excluded if clinical staff evaluates them to have significant 
cognitive or developmental impairment (i.e., unable to give informed consent). 
We will require participants be 21 and older because at CUMC those under 21 
with HIV/AIDS typically receive inpatient and outpatient care through the Center for 
Pediatric HIV Disease rather than the Adult AIDS unit. Given that adolescent and young 
adult patients in pediatric HIV clinics (at CUMC and elsewhere in NYC) tend to receive 
care intensive follow-up and support services designed to engage and retain them in 
medical care, we anticipate that the experiences of these younger patients who are 
disengaged from ongoing HIV care will differ from those of their adult counterparts. 
The inpatient population of the CUMC Adult AIDS unit is approximately 30% 
non-Hispanic Black, 60% Hispanic (predominantly of Puerto Rican and Dominican 
background), but only 5% non-Hispanic White and 5% other ethnic/racial groups. 
Therefore, it is unlikely that we could accrue a sufficient number of participants who are 




group. Therefore, the sample will be restricted to only non-Hispanic Black (henceforth 
Black) and Hispanic (of any race) participants. Furthermore, the extant literature has 
consistently identified Black and Hispanic patients as at greatest risk for disengagement 
from HIV care and preventable hospitalizations. 
HIV status will be confirmed by the nurse recruiter (who will be a clinical staff of 
CUMC) by consulting the patient’s medical record prior to their being invited to 
participate in the study. However, because patients must be aware of their HIV diagnosis 
to understand the need for HIV outpatient care and to engage in behaviors to maintain 
their health (e.g., starting antiretroviral therapy), we will also require patients to self-
report being HIV positive. Participants must also be at least 2 years post-diagnosis. This 
will allow us to focus on those who have had time to form a health lifestyle in which they 
could have engaged in care, but instead have not or have disengaged in from HIV care. 
This criterion is also imposed because when diagnosed with HIV, some individuals go 
into a period of denial that can often extend a year or more. Such patients cannot 
effectively participate in an interview about their HIV outpatient care while denying their 
HIV- positive status. Their early failure to obtain care may not be representative of their 
later pattern of HIV care, because after the initial reaction many might initiate regular 
outpatient HIV care. By restricting the sample to patients who have been diagnosed with 
HIV for two or more years, we ensure we are not capturing cases who are just in early 
denial of the diagnosis, but who once they accept their diagnosis will engage in care. 
Given the proposed study’s focus on individuals whose immune function and 
health have been significantly compromised due to their lack of care, we have included 




hospital admission (as indicated by the medical record). This is important because ART 
(and regular outpatient monitoring) is clinically indicated for all patients (by both 
aggressive and non-aggressive treatment providers) at these levels. We will also restrict 
the sample to those whose health has been compromised due to a lack of HIV care and 
therefore require hospitalization in the AIDS unit. All HIV- positive patients at CUMC, 
regardless of their reason for hospitalization, are assigned to the Adults AIDS unit unless 
they require surgery. Therefore requiring patients to be admitted to the AIDS unit will not 
result in the loss of potentially eligible patients who are hospitalized in other care units.  
We will require all participants to not have seen any HIV outpatient provider (at 
any location) in the past 6 months, because of our focus on understanding HIV-positive 
individuals disengaged from HIV outpatient care. However, we will not exclude those 
who may have utilized the emergency department, HIV-related social services, or 
substance use treatment services in the past 6 months. This 6-month criterion was chosen 
because this time period is considered by most researchers and providers as the maximum 
time gap that should occur between HIV care visits. Furthermore, Giordano et al. found 
that HIV-infected men who went two or more quarters (6 months) without an HIV 
primary care visit were nearly twice as likely to die as those who visited a provider in all 













HIV Practices and Beliefs Study 
Interviewer Administered Questionnaire 
 
Interview Date:       -      -    Start Time:   :  AM/PM End Time:  
 _: AM/PM 
 
Study Participant #:     
 
To begin with, I would like to ask you some brief questions about yourself 
that we are asking everybody so that we will be able to describe the group 
of people who are participating in the study. These questions will take 
approximately 10 minutes. 
 
1. Which of the following best describes your living situation in the past 
year…  (CIRCLE ALL THE APPLY) 
 
1 – An apartment or house that you or your family own 
2 – An apartment or house that you or your family rent, without any 
financial assistance 
3 – An apartment or house that you or your family receive assistance from 
relatives to pay the rent 
4 – An apartment or house that you or your family receive assistance from 
public assistance or another program to pay the rent (Specify program or 
type of benefit: ______) 
5 – “Doubled up” with a friend or relative (and you do not pay rent) 
6 – A room in an SRO or hotel paid for by public assistance or another 
program (Specify program or type of benefit) 
7 – A room in specialized AIDS housing paid for by public assistance or 
another program (Specify program or type of   benefit ) 
8 – Drug treatment program housing 
9 – Shelters 
10 – Street or another public place 
11 – Hospital 
12 – Nursing home, hospice 
13 – Jail or prison 
14 – Other (Specify: _____) 
97 – REFUSED 
 
1A. IF ANSWERED CATEGORIES #1 – 7 ABOVE, ASK: Whose name 
is on the lease (or mortgage)? 
1 – Your name alone 
2 – Your name and other people 
3 – Someone else 
4 – Agency maintains the lease 
5 – Not applicable – group housing/program housing 




97 – REFUSED 
 
1B.  How long can you stay in this housing?  Is there a time limit? 
0 – No time limit 
1 – One month 
2 – Three months 
3 – Six months 
4 – One year 
5 – Two years 
6 – Longer than 2 years 
97 – REFUSED 
 
1C.  Is there a social worker or case manager who is supposed to help you 
who lives there, has an office there, or who visits you as part of a housing 
program? 
1 – Yes, there is a case manager on site, in the building 
2 – Yes, a case manager visits regularly as part of a housing program 
3 – No social worker or case manager associated with housing 
4 – A social worker or outreach worker has visited you where you live, but 
they are not part of housing program 
5 – Don’t know 
97 - REFUSED 
  
2. Do you consider yourself to be currently homeless? (Again, by 
"homeless", we mean you do not have your own place to sleep--not an 
apartment you are renting and not even a friends or family member's place 
you are welcome to stay at) (Choose one) 
0 = No  (SKIP to 9) 
1 = Yes (ASK 8C) 
97 = REFUSED 
 
IF YES, ASK:  2B.  How long has it been since you had your own place? 
(Choose one) 
1= Less than a week 
2= Between 7 days and 30 days 
3= From one month to six months 
4= From six months to a year 
5= More than a year 
97= REFUSED 
 
3. Which best describes your employment status….? 
0 – Not employed 
1 – Irregular, occasional, part time work (less than 35 hours per week) 
2 – Employed part-time, regular job (less than 35 hours per week) 




4 – Employed more than full-time (works more than 1 job, totaling more 
than 40 hours per week) (SKIP TO Q5) 
5 – Not working for pay, but volunteering regularly at a program or 
agency (receive stipend) 
6 – Not working for pay, but volunteering regularly at a program or 
agency (does not receive stipend) 
 
4. What are some of the reasons for not having a full-time job or going to 
work right now? (CIRCLE ALL THAT APPLY) 
 
1 – Don’t feel well enough 
2 – Not sure will stay well enough 
3 – Fear losing medical benefits 
4 – Fear losing other benefits 
5 – Cannot find a job 
6 – Lack of education 
7 –Lack of job skills 
8 – Need to take care of children/someone else 
9 – Going to school 
10 – In drug treatment 
11 – I cannot find a job because of discrimination 
12. Retired 
13. Other (Record _________) 
97 – REFUSED 
 
5. In the last 6 months, have you gotten any MONEY from. . . . ? 
 
5A. Regular job, either full or part time  1 = Yes 
 0 = No  97 = Refused 
 5B. HASA (HIV/AIDS Services Administration) 1 = Yes 
 0 = No  97 = Refused 
5C. Disability/Social Security   1 = Yes 
 0 = No  97 = Refused 
 5D. Public Assistance    1 = Yes 
 0 = No  97 = Refused 
 5E. Selling Drugs     1 = Yes 
 0 = No  97 = Refused 
5F. Recycling, e.g., selling cans, returning bottles 1 = Yes 
 0 = No  97 = Refused 
5G. Sex for money, tricking    1 = Yes 
 0 = No  97 = Refused 
5H. Temporary work or odd jobs – off the books  1 = Yes 
 0 = No  97 = Refused 
5I. Temporary work or odd jobs – on the books 1 = Yes 




5J. Spouse or steady partner    1 = Yes 
 0 = No  97 = Refused 
5K. Family or friends     1 = Yes 
 0 = No  97 = Refused 
5L. Other (Record:  
________________________________________________________)             
 
 
 6. Do you have any of the following kinds of medical insurance?   Such 
as….  
 
 6A.  Medicaid?    0 = No   1 = Yes
 3 = Applied 97 = Refused 
 6B.  Medicare?    0 = No   1 = Yes
 3 = Applied 97 = Refused 
 6C.  Veterans benefits?   0 = No   1 = Yes
 3 = Applied 97 = Refused 
 6D. ADAP (AIDS Drug Assist. Program)  0 = No   1 = Yes
 3 = Applied97 = Refused 
 6E.  Private Insurance    
 (that you pay for yourself,  
 through work/union, or through a spouse?) 0 = No   1 = Yes
 3 = Applied97 = Refused 
 6F. Other Insurance?    0 = No   1 = Yes
 3 = Applied97 = Refused 
          (Record ____________________________________________________) 
 
 
   7. During the past 6 months, have you gone to a hospital emergency room 
for emergency care?  Include any visits to the emergency room, even if 
you were admitted to the hospital from there.  Please include emergency 
rooms of psychiatric and medical hospitals.  
 
  0 – No  
  1 – Yes     
  97 – Refused   
  8 – Don’t know   
 




Record    
97=   REFUSED 
 
 
   IF YES, 7B. During the past 6 months, were you a patient in any hospital 




  0 – No  
  1 – Yes    
  97 – Refused   
  8 – Don’t know   
 
8.   IF YES, 7C. During the past 6 months, how many times were you a 
patient in any hospital overnight or longer?   
  
  Record 
__________________________________________ 
 97 =   REFUSED 
 
 
8. What was your lowest T-cell count ever?  
 
      1 – Lowest T-cell count     
 
       Date    /   Month / Year 
 
      2 - Does not recall lowest T-cell count 
      97 – REFUSED 
 
 
8A.  Have you ever been told that your viral load was undetectable? 
 
0 – No 
1 – Yes 
2 – Does not recall 
97 – REFUSED  
 
IF YES, ASK 8B: What was the date of your most recent 
undetectable viral load?  
 






9. Have you ever gone to a doctor or clinic for HIV care? (By HIV care, I 
mean a clinic visit in which you addressed your HIV or AIDS medications 
or blood test results, such as T cell count and viral load) 
0 =   No (SKIP TO 10) 
1 =   Yes 






IF YES, ASK:  9A.  In the past 12 months have you gone to a 
doctor or clinic for HIV care? 
0 =   No (SKIP TO 10) 
1 =   Yes 
97 =   REFUSED 
 
 
IF YES, ASK:  9A.1.  In the past 12 months, how many times have 
you gone for HIV care? 
 
 
Record    
97 =   REFUSED 
 
 
IF YES, ASK: 9A.2.  In the past 6 months, how many times have 
you gone for HIV care? 
 
 
Record    
97 =   REFUSED 
 
 
10. Many times people have to miss appointments because things come up.  
How many times in the past 6 months have you had to miss a scheduled 
appointment for HIV care? 
 
 
Record    
97 =   REFUSED 
 
 
11. How likely or unlikely is it that you will go for HIV care in the next 6 
months? Would you say that it is: (CHOOSE ONE) 
 
1 =   very likely 
2 =   likely 
3 =   neither likely nor unlikely 
4 =   unlikely 
5 =   very unlikely 
97 =   REFUSED 
 
12. Do you currently take any HIV medications? 
 
0 =   No (SKIP TO 13) 
1 =   Yes 
  
IF YES, ASK 12A. Do you currently take all your HIV medications as 
directed? (As directed means taking your medications at the right time and 





1 =   NO, I do not, and I am not considering taking my HIV medications as 
directed 
2 =   NO, I do not but I am considering taking my HIV medications as 
directed. 
3 =   NO, I do not, but I am planning to start taking my HIV medications 
as directed w/in the next month. 
4 =   YES, I always take my HIV medications as directed. 
  
IF 12A. YES, ASK 12B. How long have you been taking your HIV 
medications as directed? 
1 =   2 months or less 
2 =   3 to 6 months 
3 =   7 to 12 months 
4 =   Over 1 year but less than 2 years 
5 =   2 years or more 
  
IF 12A. YES, ASK 12C. How certain are you that you will 
continue taking your medications as directed during the next 6 months? 
 
1 =   Completely certain 
2 =   Somewhat certain 
3 =   Somewhat uncertain 
4 =   Not certain at all 
  
13. Have you ever taken medications for your HIV in the past? 
 
0 =   No 
1 =   Yes 
97 =   REFUSED 
  
14. Are you thinking about, considering taking HIV medications? 
 
0 =   No 
1 =   Yes 
 
 
15. Are you planning to start taking HIV medications within the next 
month? 
 
0 =   No 
1 =   Yes 
 
   15A. IF YES Tell me right now why you are taking HIV medications. 
  _____________________________________________________________ 























































Dissertation Interview Guide 
 
 
1. How have things been going for you, how have you been doing since you talked 
with us last?  
 
 
2. Where are currently living? 
 
 
3. Have you been in jail or incarcerated since we talked to you last? 
 
 
4. Have you been hospitalized since we talked to you last (after your hospitalization 




5. How were you doing in terms of your physical and emotional health the few days 
after you left the hospital? What was going on with your health? Where did you 
go after leaving hospital?  Did you have a friend or family member to help you 
after leaving the hospital?  
 
 
6. Did your experience being in Presbyterian hospital shape in any way how you 
manage or deal with your HIV care now? 
 
 
7. Are you currently in HIV care? 
 
 
8. Are you currently using antiretroviral medication (ARTs)?  
 
 
9. At the beginning of this conversation, you told me you are/are not currently 
seeing an HIV outpatient provider/in HIV care.  
 
a. Regardless of participant’s answer, ask: Tell me a bit about this, why are 
you/aren’t you seeing an HIV outpatient provider?   
 
 
10. When you first talked with us about ____  months ago , you said there were a few 
things in particular that were challenging you (Challenge 1 from initial 






a. Let’s talk about Challenge 1 (Concrete challenge, i.e., joblessness, 
housing instability, lack of benefits, etc). How were you handling x once 
you got out of the hospital? 
 
 
b. Did that way of dealing with it work for you? 
 
 
c. (If still facing challenge): how are you handling [challenge 1] now? Is this 
a challenge you think you will be dealing in a short-term way, or long 
term?  Tell me why do you think so?  
 
 
d. Is dealing with x affecting how you deal with your HIV care?  
 
 
e. What would have to happen to help you resolve this challenge? Tell me a 




11. The second main challenge you talked about was y (Less tangible than challenge 
1, if applicable, i.e., stigma, distrust, shame, hopelessness/depression/lack of 
motivation, self-destructive tendencies etc). 
 
 
a. You told (name of interviewer) ___ months ago, that you were dealing 




b. How has ________________(way of dealing w Challenge2) been working 












e. What would have to happen to help you resolve this challenge? Tell me a 






12. If not been dealing/managing Challenge 2, ask: Tell me a bit about that, Why 
haven’t you….?  
 
 
13. Is there anything else you would like to share with me about these two challenges 
we just discussed? 
 
 
14. Is there anything else that has come up since we last spoke that is affecting you 







Ok, now I am going to ask you a few questions about medication. You told me a few 
minutes ago that you are/are not taking medications. (These questions will depend on 
if the participant was/was not already on medication at time of initial hospitalization, if 
the P began/did not begin ARTs during/after hospitalization, and their reported 
relationship with meds, generally. The P’s med trajectory will be outlined prior to the 
F/U interview attempt). 
 
15. You had said during that first interview ___ months ago that you were/were not 
planning on beginning medication. What made you decide that?  
 
 
a. If yes, on medication…When did you start on ARTs?  
 
b. How long have you been on ARTs continuously?   
 
c. How is it going with the medication? How have you been feeling on the 
meds? (i.e., side effects, restored sense of well-being etc)  
 




16. If no, not on medication….Tell me a bit about this 







17. Have your thoughts or opinions about taking ARTs changed since you were 
hospitalized ___ months ago ?  




18. Is there anything else you want to share with me about how things have been for 
you since we last spoke ___ months ago?  
 
 
19. What is your advice for things that could be put in place to help ensure that people 
with similar situations as you, are able to manage your HIV (i.e., go to outpatient 




Lay beliefs about HIV/AIDS 
 
I’m now going to ask you some questions about topics we haven’t necessarily 
addressed so far.   
 
 
20. We’ve talked to lots of people with HIV or AIDS and about their experiences 
with living with the illness. Some people have told us that they believe that 
HIV/AIDS is man-made. Others have said that there is a cure but it is being 
withheld. We have also come across people who think that HIV was created to 
infect particular groups.  
 
a. Have you ever heard these ideas or any ideas similar to these? 
 
 
b. If “yes”, have heard about these ideas ! What are some of the things 
you’ve heard? Who brought up these ideas? Probe: Was it a friend, a 
relative, an associate, someone you work with, other?  Did the person(s) 
who discuss these ideas have HIV?  What did you make of that?  
 
 
21. What are your thoughts about these ideas? 
 
 
(If Participant shares these thoughts!)  Tell me more about this.  
 
 






b. What do you think about the purpose of ART? What makes you say that?  
 
 
c. What have you experienced or observed that lead you to think that?  
 
 
d. Have you ever shared these ideas with anybody? Can you tell me with 
whom and what did they say? Has anybody ever given you a hard time 
about believing this? 
 
 
e. Have you ever talked to a health care provider about your beliefs? If so, 
what did you discuss, and how did they respond?  
 
 
i. Do you feel like they respected what you had to say? Whether yes 
or no: What do they say or do that makes you think they respect 




f. How does this affect your relationship with the provider? 
 
 
g. How does it affect your going to the doctor (in general) or the clinic?  
 
i. Going to an HIV care provider?  
 
ii. Going on ART, if your doctor says you need to? 
 
 
22.  If Participant does not share these thoughts ! Tell me more about this.  
 
 
a. What about these ideas do you not believe? What makes you say that?  
 
 
b. What is your understanding/what do you think causes AIDS?  
 
 
c. What is the purpose of ART?  
 
 










23. If “no”, have never heard about these ideas !  Have you ever heard people talk 




a. What do you think about these ideas?   
 
 
b. Why do you think some people think this?  
 
 
c. What are your thoughts about these ideas? What makes you say that?  
 
 
d. What have you experienced or observed that lead you to think that?  
 
 
e. Have you ever shared your thoughts about this with anybody? Can you tell 
me with whom and what did they say?  
 
 




24. What advice would you give to someone who is HIV positive about taking care of 








Thank you so much for your participation.  
 
